Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 20...
Uložené v:
| Vydané v: | The Lancet (British edition) Ročník 384; číslo 9947; s. 1005 - 1070 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Kidlington
Elsevier Ltd
2014
Elsevier Elsevier Limited |
| Predmet: | |
| ISSN: | 0140-6736, 1474-547X, 1474-547X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration.
To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010–13) of incidence, drug resistance, and coverage of insecticide-treated bednets.
Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990.
Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. Incidence rates for HIV, tuberculosis, and malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action.
Bill & Melinda Gates Foundation. |
|---|---|
| AbstractList | The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration.
To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets.
Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990.
Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action.
Bill & Melinda Gates Foundation. The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010–13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. Incidence rates for HIV, tuberculosis, and malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. Bill & Melinda Gates Foundation. Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010–13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. Incidence rates for HIV, tuberculosis, and malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. Background: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods: To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings: Globally in 2013, there were 1.8 million new HIV infections (95% uncertainty interval 1.7 million to 2.1 million), 29.2 million prevalent HIV cases (28.1 to 31.7), and 1.3 million HIV deaths (1.3 to 1.5). At the peak of the epidemic in 2005, HIV caused 1.7 million deaths (1.6 million to 1.9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19.1 million life-years (16.6 million to 21.5 million) have been saved, 70.3% (65.4 to 76.1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7.5 million (7.4 million to 7.7 million), prevalence was 11.9 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7.1 million (6.9 million to 7.3 million), prevalence was 11.2 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64.0% of cases (63.6 to 64.3) and 64.7% of deaths (60.8 to 70.3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1.2 million deaths (1.1 million to 1.4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31.5% (15.7 to 44.1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation: Our estimates of the number of people living with HIV are 18.7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. BACKGROUND: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. METHODS: To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. FINDINGS: Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. INTERPRETATION: Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration.BACKGROUNDThe Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration.To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets.METHODSTo estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets.Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990.FINDINGSGlobally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990.Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action.INTERPRETATIONOur estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action.Bill & Melinda Gates Foundation.FUNDINGBill & Melinda Gates Foundation. Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings Globally in 2013, there were 1.8 million new HIV infections (95% uncertainty interval 1.7 million to 2.1 million), 29.2 million prevalent HIV cases (28.1 to 31.7), and 1.3 million HIV deaths (1.3 to 1.5). At the peak of the epidemic in 2005, HIV caused 1.7 million deaths (1.6 million to 1.9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19.1 million life-years (16.6 million to 21.5 million) have been saved, 70.3% (65.4 to 76.1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7.5 million (7.4 million to 7.7 million), prevalence was 11.9 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7.1 million (6.9 million to 7.3 million), prevalence was 11.2 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64.0% of cases (63.6 to 64.3) and 64.7% of deaths (60.8 to 70.3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1.2 million deaths (1.1 million to 1.4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31.5% (15.7 to 44.1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation Our estimates of the number of people living with HIV are 18.7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. Funding Bill & Melinda Gates Foundation. Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings Globally in 2013, there were 1.8 million new HIV infections (95% uncertainty interval 1.7 million to 2.1 million), 29.2 million prevalent HIV cases (28.1 to 31.7), and 1.3 million HIV deaths (1.3 to 1.5). At the peak of the epidemic in 2005, HIV caused 1.7 million deaths (1.6 million to 1.9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19.1 million life-years (16.6 million to 21.5 million) have been saved, 70.3% (65.4 to 76.1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7.5 million (7.4 million to 7.7 million), prevalence was 11.9 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7.1 million (6.9 million to 7.3 million), prevalence was 11.2 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64.0% of cases (63.6 to 64.3) and 64.7% of deaths (60.8 to 70.3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1.2 million deaths (1.1 million to 1.4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31.5% (15.7 to 44.1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation Our estimates of the number of people living with HIV are 18.7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. Funding Bill & Melinda Gates Foundation. Summary Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. Methods To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010–13) of incidence, drug resistance, and coverage of insecticide-treated bednets. Findings Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. Interpretation Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. Incidence rates for HIV, tuberculosis, and malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. Funding Bill & Melinda Gates Foundation. |
| Author | Kankindi, Ida Roy, Nobhojit Abraham, Jerry P Khang, Young-Ho Gaffikin, Lynne Tran, Bach X Violante, Francesco S Al Kahbouri, Mazin J Bhala, Neeraj Del Pozo-Cruz, Borja Sykes, Bryan L Naghavi, Mohsen Larsson, Anders Moore, Ami R Gankpé, Fortuné Gbètoho Hamadeh, Randah Ribhi Ortblad, Katrina F Durrani, Adnan M De Lima, Graça Maria Ferreira Wolock, Timothy M Larson, Heidi J Pourmalek, Farshad Quezada, Amado D Majdan, Marek Caicedo, Angel J Paternina Stathopoulou, Vasiliki Kalliopi Coggeshall, Megan S Mazorodze, Tasara T Soneji, Samir Talongwa, Roberto Tchio Amare, Azmeraw T Iburg, Kim M Abera, Semaw Ferede Kokubo, Yoshihiro Murthy, Kinnari S Mason-Jones, Amanda J Bhalla, Ashish Lai, Taavi Kan, Haidong Shiue, Ivy Yoon, Seok-Jun Albittar, Mohammed I Assadi, Reza Cowie, Benjamin C Brainin, Michael Goto, Atsushi El Sayed Zaki, Maysaa Hammami, Mouhanad Neupane, Sudan Prasad Vlassov, Vasiliy Victorovich Lotufo, Paulo A Hoek, Hans W Jiang, Guohong Mejia-Rodriguez, Fabiola Mohammad, Karzan Abdulmuhsin Balakrishnan, Kalpana Dessalegn, Muluken Williams, |
| Author_xml | – sequence: 9 givenname: Ryan M surname: Barber fullname: Barber, Ryan M organization: Institute for Health Metrics and Evaluation, Seattle, WA, USA – sequence: 11 givenname: Haidong surname: Wang fullname: Wang, Haidong organization: Institute for Health Metrics and Evaluation, Seattle, WA, USA – sequence: 14 givenname: Daniel surname: Dicker fullname: Dicker, Daniel organization: Institute for Health Metrics and Evaluation, Seattle, WA, USA – sequence: 16 givenname: Joshua A surname: Salomon fullname: Salomon, Joshua A organization: Harvard University, Cambridge, MA, USA – sequence: 18 givenname: Kyle surname: Foreman fullname: Foreman, Kyle organization: Imperial College London, London, UK – sequence: 23 givenname: Elizabeth K surname: Johnson fullname: Johnson, Elizabeth K organization: Institute for Health Metrics and Evaluation, Seattle, WA, USA – sequence: 24 givenname: Megan S surname: Coggeshall fullname: Coggeshall, Megan S organization: Institute for Health Metrics and Evaluation, Seattle, WA, USA – sequence: 26 givenname: Semaw Ferede surname: Abera fullname: Abera, Semaw Ferede organization: College of Health Sciences, School of Public Health, Mekelle, Ethiopia – sequence: 28 givenname: Ibrahim surname: Abubakar fullname: Abubakar, Ibrahim organization: University College London, London, UK – sequence: 34 givenname: José C surname: Adsuar fullname: Adsuar, José C organization: University of Extremadura, Cáceres, Spain – sequence: 35 givenname: Emilie Elisabet surname: Agardh fullname: Agardh, Emilie Elisabet organization: Institution of Public Health Sciences, Stockholm, Sweden – sequence: 40 givenname: Gabriel surname: Alcalá-Cerra fullname: Alcalá-Cerra, Gabriel organization: Grupo de Investigación en Ciencias de la Salud y Neurociencias (CISNEURO), Cartagena de Indias, Colombia – sequence: 45 givenname: Raghib surname: Ali fullname: Ali, Raghib organization: University of Oxford, Oxford, UK – sequence: 53 givenname: Hassan surname: Amini fullname: Amini, Hassan organization: Kurdistan Environmental Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Kurdistan, Iran – sequence: 54 givenname: Walid surname: Ammar fullname: Ammar, Walid organization: Ministry of Public Health, Beirut, Lebanon – sequence: 58 givenname: Johan surname: Ärnlöv fullname: Ärnlöv, Johan organization: Uppsala University, Uppsala, Sweden – sequence: 60 givenname: Ali surname: Artaman fullname: Artaman, Ali organization: Median Inc, Windsor, ON, Canada – sequence: 61 givenname: Rana J surname: Asghar fullname: Asghar, Rana J organization: South Asian Public Health Forum, Islamabad, Pakistan – sequence: 65 givenname: Kalpana surname: Balakrishnan fullname: Balakrishnan, Kalpana organization: Sri Ramachandra University, Chennai, India – sequence: 68 givenname: Justin surname: Beardsley fullname: Beardsley, Justin organization: Oxford University, Ho Chi Minh City, Vietnam – sequence: 73 givenname: Neeraj surname: Bhala fullname: Bhala, Neeraj organization: Wellington Hospital, Wellington, New Zealand – sequence: 79 givenname: Berrak Bora surname: Basara fullname: Basara, Berrak Bora organization: General Directorate of Health Research, Ankara, Turkey – sequence: 82 givenname: Nicholas surname: Breitborde fullname: Breitborde, Nicholas organization: University of Arizona, Tucson, AZ, USA – sequence: 86 givenname: Jung-Chen surname: Chang fullname: Chang, Jung-Chen organization: National Taiwan University, Taipei, Taiwan – sequence: 88 givenname: Ting-Wu surname: Chuang fullname: Chuang, Ting-Wu organization: Department of Parasitology, College of Medicine, Taipei Medical University, Taipei, Taiwan – sequence: 98 givenname: Louisa surname: Degenhardt fullname: Degenhardt, Louisa organization: University of New South Wales, Sydney, NSW, Australia – sequence: 99 givenname: Borja surname: Del Pozo-Cruz fullname: Del Pozo-Cruz, Borja organization: University of Auckland, Auckland, New Zealand – sequence: 103 givenname: Samath D surname: Dharmaratne fullname: Dharmaratne, Samath D organization: University of Peradeniya, Peradeniya, Sri Lanka – sequence: 112 givenname: Farshad surname: Farzadfar fullname: Farzadfar, Farshad organization: Non-Communicable Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran – sequence: 113 givenname: Seyed-Mohammad surname: Fereshtehnejad fullname: Fereshtehnejad, Seyed-Mohammad organization: Department of Neurobiology, Care Sciences and Society (NVS), Stockholm, Sweden – sequence: 115 givenname: Mohammad H surname: Forouzanfar fullname: Forouzanfar, Mohammad H organization: Institute for Health Metrics and Evaluation, Seattle, WA, USA – sequence: 116 givenname: Urbano surname: Fra.Paleo fullname: Fra.Paleo, Urbano organization: University of Extremadura, Cáceres, Spain – sequence: 117 givenname: Lynne surname: Gaffikin fullname: Gaffikin, Lynne organization: Stanford University School of Medicine, Stanford, CA, USA – sequence: 119 givenname: Fortuné Gbètoho surname: Gankpé fullname: Gankpé, Fortuné Gbètoho organization: Clinique Coopérative de Parakou, Parakou, Borgou, Benin – sequence: 122 givenname: Katherine B surname: Gibney fullname: Gibney, Katherine B organization: Monash University, Melbourne, VIC, Australia – sequence: 132 givenname: Randah Ribhi surname: Hamadeh fullname: Hamadeh, Randah Ribhi organization: Arabian Gulf University, Manama, Bahrain – sequence: 133 givenname: Mouhanad surname: Hammami fullname: Hammami, Mouhanad organization: Wayne County Department of Health and Human Services, Detroit, MI, USA – sequence: 135 givenname: Hilda L surname: Harb fullname: Harb, Hilda L organization: Ministry of Public Health, Beirut, Lebanon – sequence: 138 givenname: Simon I surname: Hay fullname: Hay, Simon I organization: University of Oxford, Oxford, UK – sequence: 140 givenname: Ileana B Heredia surname: Pi fullname: Pi, Ileana B Heredia organization: National Institute of Public Health of Mexico, Cuernavaca, Morelos, Mexico – sequence: 142 givenname: John C surname: Hornberger fullname: Hornberger, John C organization: Cedar Associates, Menlo Park, CA, USA – sequence: 144 givenname: Peter J surname: Hotez fullname: Hotez, Peter J organization: Baylor College of Medicine, Houston, TX, USA – sequence: 153 givenname: Vivekanand surname: Jha fullname: Jha, Vivekanand organization: Postgraduate Institute of Medical Education and Research, Chandigarh, India – sequence: 155 givenname: Jost B surname: Jonas fullname: Jonas, Jost B organization: Department of Ophthalmology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany – sequence: 158 givenname: Ida surname: Kankindi fullname: Kankindi, Ida organization: Ministry of Health, Kigali, Rwanda – sequence: 162 givenname: Anil surname: Kaul fullname: Kaul, Anil organization: Oklahoma State University, Tulsa, OK, USA – sequence: 163 givenname: Norito surname: Kawakami fullname: Kawakami, Norito organization: School of Public Health, Tokyo, Japan – sequence: 164 givenname: Dhruv S surname: Kazi fullname: Kazi, Dhruv S organization: University of California San Francisco, San Francisco, CA, USA – sequence: 167 givenname: Andre surname: Keren fullname: Keren, Andre organization: Cardiology, Hadassah Ein Kerem University Hospital, Jerusalem, Israel – sequence: 171 givenname: Ejaz Ahmed surname: Khan fullname: Khan, Ejaz Ahmed organization: Health Services Academy, Islamabad, Punjab, Pakistan – sequence: 174 givenname: Yohannes surname: Kinfu fullname: Kinfu, Yohannes organization: University of Canberra, Canberra, ACT, Australia – sequence: 178 givenname: S surname: Kosen fullname: Kosen, S organization: Center for Community Empowerment, Health Policy & Humanities, NIHRD, Jakarta, Indonesia – sequence: 179 givenname: Barthelemy Kuate surname: Defo fullname: Defo, Barthelemy Kuate organization: University of Montreal, Montreal, QC, Canada – sequence: 184 givenname: G Anil surname: Kumar fullname: Kumar, G Anil organization: Public Health Foundation of India, New Delhi, India – sequence: 187 givenname: Arjun Lakshmana surname: Balaji fullname: Balaji, Arjun Lakshmana organization: University of Melbourne, Melbourne, VIC, Australia – sequence: 197 givenname: Yichong surname: Li fullname: Li, Yichong organization: Genentech, Inc, South San Francisco, CA, USA – sequence: 198 givenname: Yongmei surname: Li fullname: Li, Yongmei organization: Genentech, Inc, South San Francisco, CA, USA – sequence: 208 givenname: Carlos surname: Magis-Rodriguez fullname: Magis-Rodriguez, Carlos organization: Centro Nacional para la Prevención y el Control del VIH/SIDA, Mexico City, Mexico – sequence: 209 givenname: Marek surname: Majdan fullname: Majdan, Marek organization: Department of Public Health, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovakia – sequence: 224 givenname: Walter surname: Mendoza fullname: Mendoza, Walter organization: UNFPA, Lima, Peru – sequence: 234 givenname: Wilkister Nyaora surname: Moturi fullname: Moturi, Wilkister Nyaora organization: Egerton University, Egerton, Rift Valley, Kenya – sequence: 239 givenname: Luigi surname: Naldi fullname: Naldi, Luigi organization: Azienda Ospedaliera papa Giovanni XXIII, Bergamo, Italy – sequence: 244 givenname: Robert G surname: Nelson fullname: Nelson, Robert G organization: National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA – sequence: 248 givenname: Muhammad Imran surname: Nisar fullname: Nisar, Muhammad Imran organization: Aga Khan University, Karachi, Pakistan – sequence: 249 givenname: Sandra surname: Nolte fullname: Nolte, Sandra organization: Charité Universitätsmedizin Berlin, Berlin, Germany – sequence: 252 givenname: Luke surname: Nyakarahuka fullname: Nyakarahuka, Luke organization: Makerere University, Kampala, Uganda – sequence: 255 givenname: Bolajoko O surname: Olusanya fullname: Olusanya, Bolajoko O organization: Center for Healthy Start Initiative, Ikoyi, Lagos, Nigeria – sequence: 256 givenname: Saad B surname: Omer fullname: Omer, Saad B organization: Emory University, Atlanta, GA, USA – sequence: 257 givenname: John Nelson surname: Opio fullname: Opio, John Nelson organization: Lira District Local Government, Lira Municipal Council, Northern Uganda, Uganda – sequence: 268 givenname: Konrad surname: Pesudovs fullname: Pesudovs, Konrad organization: Flinders University, Adelaide, SA, Australia – sequence: 271 givenname: Dima surname: Qato fullname: Qato, Dima organization: College of Pharmacy, University of Illinois, Chicago, IL, USA – sequence: 276 givenname: Vafa surname: Rahimi-Movaghar fullname: Rahimi-Movaghar, Vafa organization: Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran – sequence: 279 givenname: Saleem M surname: Rana fullname: Rana, Saleem M organization: Department of Public Health, University of the Punjab, Lahore, Punjab, Pakistan – sequence: 286 givenname: Nsanzimana surname: Sabin fullname: Sabin, Nsanzimana organization: Rwanda Bio-Medical Center, Kigali, Rwanda – sequence: 287 givenname: Mohammad Yahya surname: Saeedi fullname: Saeedi, Mohammad Yahya organization: Ministry of Health, Riyadh, Saudi Arabia – sequence: 289 givenname: Genesis May J surname: Samonte fullname: Samonte, Genesis May J organization: National HIV/AIDS & STI Surveillance and Strategic Information Unit, National Epidemiology Center, Department of Health, Manila, National Capital Region, Philippines – sequence: 292 givenname: David C surname: Schwebel fullname: Schwebel, David C organization: University of Alabama at Birmingham, Birmingham, AL, USA – sequence: 296 givenname: Sara surname: Sheikhbahaei fullname: Sheikhbahaei, Sara organization: Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran – sequence: 303 givenname: Andrea P surname: Silva fullname: Silva, Andrea P organization: Instituto Nacional de Epidemiología Dr Juan H Jara, Mar del Plata, Buenos Aires, Argentina – sequence: 304 givenname: Edgar P surname: Simard fullname: Simard, Edgar P organization: Surveillance and Health Services Research Program American Cancer Society, Atlanta, GA, USA – sequence: 307 givenname: Karen surname: Sliwa fullname: Sliwa, Karen organization: Faculty of Health Sciences, Hatter Institute for Cardiovascular Research in Africa, Cape Town, Western Cape, South Africa – sequence: 310 givenname: Chandrashekhar T surname: Sreeramareddy fullname: Sreeramareddy, Chandrashekhar T organization: Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman, Kajang, Selangor, Malaysia – sequence: 312 givenname: Konstantinos surname: Stroumpoulis fullname: Stroumpoulis, Konstantinos organization: KEELPNO (Centre for Disease Control, Greece, dispatched to “Alexandra” General Hospital of Athens), Athens, Greece – sequence: 315 givenname: Karen M surname: Tabb fullname: Tabb, Karen M organization: University of Illinois, Champaign, IL, USA – sequence: 316 givenname: Roberto Tchio surname: Talongwa fullname: Talongwa, Roberto Tchio organization: Ministry of Health–MINSANTE, Yaounde, Centre, Cameroon – sequence: 319 givenname: Alan J surname: Thomson fullname: Thomson, Alan J organization: Adaptive Knowledge Management, Victoria, BC, Canada – sequence: 323 givenname: Bach X surname: Tran fullname: Tran, Bach X organization: Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA – sequence: 324 givenname: Zacharie Tsala surname: Dimbuene fullname: Dimbuene, Zacharie Tsala organization: Department of Population Sciences and Development, Faculty of Economics and Management, University of Kinshasa, Kinshasa, Democratic Republic of the Congo – sequence: 325 givenname: Miltiadis surname: Tsilimbaris fullname: Tsilimbaris, Miltiadis organization: Department of Medicine, University of Crete, Heraklion, Greece – sequence: 330 givenname: Tommi J surname: Vasankari fullname: Vasankari, Tommi J organization: UKK Institute for Health Promotion Research, Tampere, Finland – sequence: 331 givenname: N surname: Venketasubramanian fullname: Venketasubramanian, N organization: Neuroscience Centre, Raffles Hospital, Singapore, Singapore – sequence: 333 givenname: Vasiliy Victorovich surname: Vlassov fullname: Vlassov, Vasiliy Victorovich organization: Higher School of Economics, Moscow, Russia – sequence: 334 givenname: Stein Emil surname: Vollset fullname: Vollset, Stein Emil organization: Norwegian Institute of Public Health, Oslo, Norway – sequence: 339 givenname: Yanping surname: Wang fullname: Wang, Yanping organization: National Office for Maternal and Child Health Surveillance, Chengdu, China – sequence: 341 givenname: Elisabete surname: Weiderpass fullname: Weiderpass, Elisabete organization: Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden – sequence: 343 givenname: Ronny surname: Westerman fullname: Westerman, Ronny organization: University of Marburg, Marburg, Germany – sequence: 352 givenname: Gokalp Kadri surname: Yentur fullname: Yentur, Gokalp Kadri organization: General Directorate of Health Research, Ankara, Turkey – sequence: 354 givenname: Naohiro surname: Yonemoto fullname: Yonemoto, Naohiro organization: National Center of Neurology and Psychiatry, Kodira, Tokyo, Japan – sequence: 363 givenname: Jun surname: Zhu fullname: Zhu, Jun organization: National Office for Maternal and Child Health Surveillance, Chengdu, China – sequence: 365 givenname: Alan D surname: Lopez fullname: Lopez, Alan D organization: University of Melbourne, Melbourne, VIC, Australia |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28750108$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/25059949$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:du-21324$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-229029$$DView record from Swedish Publication Index (Uppsala universitet) https://gup.ub.gu.se/publication/203989$$DView record from Swedish Publication Index (Göteborgs universitet) http://kipublications.ki.se/Default.aspx?queryparsed=id:129737235$$DView record from Swedish Publication Index (Karolinska Institutet) |
| BookMark | eNqNk-1O1TAYxxeDkRe9BE0TY4KRadt1bxgxCAokJH7AEL81XdcdCj3tsV0h55v34IV4T16J7XZAIcHjp3bPfv_f2q7PerKijRZJ8hTB1wii4s0JRASmRZkVm4i8LGBFSFo9SNYQKUmak_LrSrJ2g6wm686dQwhJAfNHySrOYV7XpF5Lfh4o0zC1BayYSKPjjOkWaNYPT0BqLluhuRjKU2N7pmQ_B52x4PDodAv0vhGWe2WcdGN2yhSzkoHWW6knANU1_PX9B4Yo2wYMuLnrxTToeYCZmofYIOvPBBjXAj54Gz4JTAf2pRPMCXDS-3YOouJx8rBjyokni3EjOf308cveYXr8-eBob_c45QiSsk-7nFeQIYbrrMpL1GDchpFknJUd5mULRYMRLsPZMNawCtdhrJowQw1EZYayjWR7FF-xidBhI0JTzSyXjhomqZKNZXZOr7ylWsVh5htHSQUJhCGcjmF3JUKdzqycRjomF6WLMBM0x4Gu_8lP_IyG0sRHHge6ivzWvfy-PN2lxk6o9xTjGuKIv1qOtwFHGSaB3hnpgE5Fy4XuLVO3QrffaHlGJ-aSEgxxVpVBsLkQWPPNC9fTqXRcKMW0MN5RVGR5IOFwUEvQvMCEIFzlAX1-Bz033oYrFIUY53VZBOlG8uzvxd-s-vrGB-DFAmCOM9VZpuM_veGqMocIVoF7O3LcGues6CiX_dAVYc9SUQRp7EM69CGNTUYRoUMf0pjO76SvP7As937MiXC3L6Ww1HEZ26-VVvCetkYuNezcMXAltQxbvRBz4f6cGXWYwlESHYgMhih4d7_gPxbwG5ffdCs |
| CODEN | LANCAO |
| CitedBy_id | crossref_primary_10_3390_ijerph15112375 crossref_primary_10_1007_s11904_014_0237_5 crossref_primary_10_1016_j_lanwpc_2021_100111 crossref_primary_10_1016_j_medmal_2019_06_002 crossref_primary_10_1038_nri_2017_138 crossref_primary_10_1136_gutjnl_2015_310421 crossref_primary_10_1038_s41598_024_62497_y crossref_primary_10_1016_j_pt_2016_11_006 crossref_primary_10_3390_pathogens11080851 crossref_primary_10_1097_MD_0000000000001628 crossref_primary_10_3390_ijerph15010110 crossref_primary_10_1186_s12916_021_02224_w crossref_primary_10_1186_s12960_023_00854_0 crossref_primary_10_1080_14787210_2016_1177457 crossref_primary_10_1093_trstmh_try128 crossref_primary_10_3389_fimmu_2018_00090 crossref_primary_10_1590_0102_311x00050916 crossref_primary_10_1016_j_bmc_2015_03_008 crossref_primary_10_1371_journal_pone_0131353 crossref_primary_10_1016_j_jsbmb_2016_04_015 crossref_primary_10_1007_s13365_016_0483_y crossref_primary_10_1093_infdis_jiz138 crossref_primary_10_1186_s12936_015_1048_x crossref_primary_10_1371_journal_pone_0192880 crossref_primary_10_1089_bfm_2016_0087 crossref_primary_10_3402_gha_v9_32298 crossref_primary_10_1111_jvh_12616 crossref_primary_10_1126_science_1257099 crossref_primary_10_1186_s12966_016_0447_x crossref_primary_10_1371_journal_pone_0180516 crossref_primary_10_1016_j_cdtm_2018_02_005 crossref_primary_10_1186_s12889_016_2925_0 crossref_primary_10_2106_JBJS_16_00323 crossref_primary_10_1080_10409238_2017_1287161 crossref_primary_10_3389_fmed_2019_00075 crossref_primary_10_3934_publichealth_2020067 crossref_primary_10_1016_j_ijid_2018_07_001 crossref_primary_10_1016_S0140_6736_14_61591_9 crossref_primary_10_1016_j_glohj_2019_11_004 crossref_primary_10_1186_s12915_020_00859_4 crossref_primary_10_1017_S0950268815001351 crossref_primary_10_1200_JGO_2015_001701 crossref_primary_10_1177_0956462420960632 crossref_primary_10_1186_1475_2875_13_419 crossref_primary_10_1016_j_cmi_2018_02_011 crossref_primary_10_1186_1475_2875_13_414 crossref_primary_10_1186_s12936_015_1036_1 crossref_primary_10_1097_QAI_0000000000001011 crossref_primary_10_1016_j_chembiol_2018_06_009 crossref_primary_10_1080_14737167_2017_1246185 crossref_primary_10_1515_ap_2016_0115 crossref_primary_10_1265_ehpm_25_00038 crossref_primary_10_1371_journal_pone_0201305 crossref_primary_10_1371_journal_pone_0173091 crossref_primary_10_3390_cells9071654 crossref_primary_10_1097_MD_0000000000022583 crossref_primary_10_1186_s12936_018_2184_x crossref_primary_10_1186_s12916_017_0983_5 crossref_primary_10_1371_journal_pcbi_1004308 crossref_primary_10_1016_j_ijpharm_2025_125517 crossref_primary_10_3389_fimmu_2018_03136 crossref_primary_10_3390_microorganisms9071431 crossref_primary_10_1136_jramc_2018_001154 crossref_primary_10_3389_fpubh_2023_1168805 crossref_primary_10_1186_s12936_017_2071_x crossref_primary_10_1093_trstmh_try138 crossref_primary_10_3201_eid2403_170785 crossref_primary_10_1007_s15010_024_02206_z crossref_primary_10_1186_s12916_020_01876_4 crossref_primary_10_1186_s12936_023_04470_0 crossref_primary_10_1016_j_ijtb_2017_08_007 crossref_primary_10_3109_23744235_2015_1061203 crossref_primary_10_17795_ijpbs_5392 crossref_primary_10_1002_anie_202212514 crossref_primary_10_1186_s12879_016_1392_7 crossref_primary_10_1016_S0140_6736_15_60024_1 crossref_primary_10_1186_s12936_016_1479_z crossref_primary_10_1371_journal_pone_0139169 crossref_primary_10_1016_j_ctim_2017_03_001 crossref_primary_10_1093_infdis_jiaa139 crossref_primary_10_12688_f1000research_9699_1 crossref_primary_10_1186_s12936_016_1587_9 crossref_primary_10_12688_f1000research_9699_2 crossref_primary_10_1097_QAI_0000000000001112 crossref_primary_10_1093_inthealth_ihw038 crossref_primary_10_1007_s15010_015_0834_2 crossref_primary_10_1177_0956462415624075 crossref_primary_10_2105_AJPH_2015_302716 crossref_primary_10_3389_fpubh_2025_1551612 crossref_primary_10_1016_S2414_6447_19_30057_0 crossref_primary_10_1371_journal_pone_0246131 crossref_primary_10_1371_journal_pone_0212264 crossref_primary_10_3389_fmicb_2016_00862 crossref_primary_10_4103_0971_5916_193278 crossref_primary_10_1186_s12936_025_05244_6 crossref_primary_10_1016_S0140_6736_16_31467_2 crossref_primary_10_1186_s12963_016_0112_2 crossref_primary_10_1093_ije_dyy174 crossref_primary_10_1186_s12879_015_0960_6 crossref_primary_10_4103_1319_3767_161635 crossref_primary_10_1056_NEJMoa1606701 crossref_primary_10_1016_S2352_3018_15_00023_5 crossref_primary_10_1080_1061186X_2024_2356751 crossref_primary_10_1136_bmjopen_2021_050911 crossref_primary_10_1016_j_vaccine_2015_10_115 crossref_primary_10_1080_09273948_2019_1704024 crossref_primary_10_1016_j_smhl_2020_100117 crossref_primary_10_1371_journal_pone_0174391 crossref_primary_10_1007_s43630_021_00017_x crossref_primary_10_1016_S0140_6736_15_00324_4 crossref_primary_10_15252_emmm_201606188 crossref_primary_10_5694_mja14_01760 crossref_primary_10_12688_wellcomeopenres_14761_4 crossref_primary_10_12688_wellcomeopenres_14598_2 crossref_primary_10_1016_j_heliyon_2023_e16519 crossref_primary_10_1186_s40249_017_0310_6 crossref_primary_10_12688_wellcomeopenres_14598_3 crossref_primary_10_1136_bmjopen_2018_024409 crossref_primary_10_12688_wellcomeopenres_14598_1 crossref_primary_10_1080_22201181_2016_1201935 crossref_primary_10_1371_journal_pone_0141230 crossref_primary_10_12688_wellcomeopenres_14761_1 crossref_primary_10_1186_s12884_016_1096_4 crossref_primary_10_1016_j_diii_2021_05_011 crossref_primary_10_12688_wellcomeopenres_14761_3 crossref_primary_10_12688_wellcomeopenres_14761_2 crossref_primary_10_1097_QAD_0000000000001081 crossref_primary_10_1186_s12879_017_2249_4 crossref_primary_10_1590_0102_311X00026715 crossref_primary_10_1007_s10461_016_1569_5 crossref_primary_10_3171_2016_9_SPINE16174 crossref_primary_10_3389_fmicb_2025_1622769 crossref_primary_10_1097_QAI_0000000000001209 crossref_primary_10_3389_fcimb_2022_1018699 crossref_primary_10_1007_s00466_020_01861_x crossref_primary_10_1080_20477724_2015_1133033 crossref_primary_10_1590_0102_311X00010014 crossref_primary_10_1590_1518_8345_3019_3218 crossref_primary_10_1186_s40249_016_0222_x crossref_primary_10_1007_s10597_016_0003_9 crossref_primary_10_1007_s00436_019_06210_3 crossref_primary_10_1186_s13071_017_2539_0 crossref_primary_10_7448_IAS_20_1_21395 crossref_primary_10_1186_s12911_020_01157_3 crossref_primary_10_1186_s12879_016_1685_x crossref_primary_10_2989_16085906_2016_1257495 crossref_primary_10_1080_17290376_2018_1520144 crossref_primary_10_1080_14656566_2018_1472766 crossref_primary_10_1016_j_drugalcdep_2016_11_006 crossref_primary_10_1071_SH16056 crossref_primary_10_1186_s12936_015_0822_0 crossref_primary_10_1093_ofid_ofy060 crossref_primary_10_1111_bjd_17084 crossref_primary_10_1111_myc_12382 crossref_primary_10_1111_myc_12383 crossref_primary_10_3109_08830185_2015_1082177 crossref_primary_10_1136_jramc_2014_000375 crossref_primary_10_1007_s11255_016_1452_3 crossref_primary_10_1186_s13071_019_3803_2 crossref_primary_10_1016_S0140_6736_14_61222_8 crossref_primary_10_1016_j_meegid_2016_03_018 crossref_primary_10_1080_14737167_2020_1734456 crossref_primary_10_1371_journal_pone_0141335 crossref_primary_10_1007_s00381_015_2912_2 crossref_primary_10_1093_infdis_jiv055 crossref_primary_10_1093_infdis_jiy686 crossref_primary_10_1111_risa_13529 crossref_primary_10_1016_S1473_3099_17_30703_X crossref_primary_10_1016_S0140_6736_14_61682_2 crossref_primary_10_1126_scitranslmed_aaf2944 crossref_primary_10_1007_s10865_015_9710_x crossref_primary_10_1136_bmjopen_2015_009656 crossref_primary_10_1186_s40249_020_00719_x crossref_primary_10_1186_s12348_020_00218_y crossref_primary_10_1186_s12879_021_06582_x crossref_primary_10_1080_09273948_2020_1744669 crossref_primary_10_3389_fped_2014_00138 crossref_primary_10_3389_fpubh_2023_1093310 crossref_primary_10_1371_journal_pntd_0006477 crossref_primary_10_1016_j_ijtb_2018_08_004 crossref_primary_10_1186_s12936_017_1919_4 crossref_primary_10_1186_s12916_015_0341_4 crossref_primary_10_1371_journal_pntd_0004042 crossref_primary_10_1016_j_addr_2017_12_001 crossref_primary_10_1016_j_smhl_2017_04_003 crossref_primary_10_3389_fphar_2017_00300 crossref_primary_10_1016_j_pt_2015_06_009 crossref_primary_10_1164_rccm_201611_2346OC crossref_primary_10_1038_srep09064 crossref_primary_10_1080_02648725_2018_1482101 crossref_primary_10_1080_23120053_2016_1192822 crossref_primary_10_1161_CIRCULATIONAHA_117_033369 crossref_primary_10_52872_001c_117353 crossref_primary_10_1016_j_ijtb_2019_02_007 crossref_primary_10_1186_s12936_015_1071_y crossref_primary_10_1177_1010539517751746 crossref_primary_10_13005_bbra_2774 crossref_primary_10_1016_S0140_6736_15_60753_X crossref_primary_10_1016_j_ijid_2016_10_012 crossref_primary_10_1210_en_2017_00359 crossref_primary_10_14789_jmj_61_370 crossref_primary_10_3390_microorganisms9020338 crossref_primary_10_1016_j_soin_2019_02_002 crossref_primary_10_1155_2016_7980869 crossref_primary_10_1016_j_ehb_2021_101040 crossref_primary_10_3389_fmicb_2021_786111 crossref_primary_10_1186_s12984_018_0418_3 crossref_primary_10_3389_fmars_2019_00605 crossref_primary_10_7861_clinmed_2019_0180 crossref_primary_10_12968_bjon_2015_24_3_168 crossref_primary_10_1007_s11255_019_02321_z crossref_primary_10_1111_bju_15659 crossref_primary_10_1080_16549716_2020_1856471 crossref_primary_10_1371_journal_pone_0223308 crossref_primary_10_1212_CPJ_0000000000000517 crossref_primary_10_1186_s12992_017_0249_1 crossref_primary_10_1186_s12865_015_0092_1 crossref_primary_10_1016_j_eimce_2017_05_005 crossref_primary_10_1136_archdischild_2015_308720 crossref_primary_10_1016_j_actatropica_2022_106675 crossref_primary_10_1186_s12885_016_2080_0 crossref_primary_10_1016_j_ab_2018_06_030 crossref_primary_10_1002_ange_202212514 crossref_primary_10_1038_sdata_2015_12 crossref_primary_10_1016_S2352_3018_16_30087_X crossref_primary_10_1093_cid_civ709 crossref_primary_10_1017_S0963180123000415 crossref_primary_10_1186_s12913_020_05538_2 crossref_primary_10_1097_WCO_0000000000000934 crossref_primary_10_1093_cid_cix1019 crossref_primary_10_1111_resp_13078 crossref_primary_10_1007_s00038_016_0859_z crossref_primary_10_1093_cid_civ609 crossref_primary_10_1097_QAI_0000000000001185 crossref_primary_10_1155_2015_639107 crossref_primary_10_1016_j_prevetmed_2017_01_003 crossref_primary_10_1371_journal_pone_0187938 crossref_primary_10_1111_hsc_13075 crossref_primary_10_1016_j_heliyon_2023_e23479 crossref_primary_10_1136_bmjopen_2022_062352 crossref_primary_10_1016_S0140_6736_16_30167_2 crossref_primary_10_1186_s12889_021_12391_3 crossref_primary_10_1371_journal_pone_0171294 crossref_primary_10_1016_j_amjcard_2020_04_019 crossref_primary_10_1186_s12890_021_01567_7 crossref_primary_10_7705_biomedica_7664 crossref_primary_10_1080_1062936X_2017_1320585 crossref_primary_10_1111_imr_12257 crossref_primary_10_3390_nu8060299 crossref_primary_10_1007_s12098_019_03098_w crossref_primary_10_1186_s12879_016_1578_z crossref_primary_10_1093_cid_civ613 crossref_primary_10_1371_journal_pone_0185644 crossref_primary_10_1007_s10461_019_02487_8 crossref_primary_10_1186_s12916_016_0653_z crossref_primary_10_20518_tjph_326771 crossref_primary_10_1080_14787210_2018_1513324 crossref_primary_10_1097_CM9_0000000000000647 crossref_primary_10_1097_OLQ_0000000000002070 crossref_primary_10_1186_s12936_017_1997_3 crossref_primary_10_1016_S1473_3099_16_30259_6 crossref_primary_10_1016_S2352_3018_24_00212_1 crossref_primary_10_1186_s12960_017_0212_5 crossref_primary_10_1186_s12963_017_0145_1 crossref_primary_10_1016_j_socscimed_2016_10_020 crossref_primary_10_1056_NEJMc1701144 crossref_primary_10_1186_s12955_018_0919_6 crossref_primary_10_3389_fpubh_2016_00166 crossref_primary_10_1016_S0140_6736_16_30168_4 crossref_primary_10_1080_09540121_2018_1456642 crossref_primary_10_1148_rg_2015140317 crossref_primary_10_1093_cid_ciw836 crossref_primary_10_22207_JPAM_17_1_47 crossref_primary_10_3402_gha_v9_32943 crossref_primary_10_1016_j_idh_2018_01_002 crossref_primary_10_1194_jlr_M082784 crossref_primary_10_1007_s10067_020_05159_4 crossref_primary_10_1016_S0140_6736_15_61340_X crossref_primary_10_1097_QAD_0000000000000947 crossref_primary_10_1186_s12913_016_1804_9 crossref_primary_10_1136_bmjopen_2020_036832 crossref_primary_10_1007_s00580_022_03354_0 crossref_primary_10_1074_jbc_M114_625665 crossref_primary_10_1186_s12981_025_00767_z crossref_primary_10_1155_2015_735615 crossref_primary_10_1016_j_ijtb_2024_04_005 crossref_primary_10_1177_23259582231189094 crossref_primary_10_1371_journal_pone_0252106 crossref_primary_10_3390_ijerph182010678 crossref_primary_10_5301_tj_5000432 crossref_primary_10_1016_S0140_6736_16_00579_1 crossref_primary_10_3390_v15020444 crossref_primary_10_1186_s12936_016_1208_7 crossref_primary_10_1016_j_ijid_2015_06_016 crossref_primary_10_1371_journal_pone_0207663 crossref_primary_10_1016_j_shpsc_2016_02_007 crossref_primary_10_1186_s40794_019_0090_z crossref_primary_10_1155_2015_261864 crossref_primary_10_1002_phar_2380 crossref_primary_10_1177_11782218231177515 crossref_primary_10_1186_s12916_015_0306_7 crossref_primary_10_1186_s40199_016_0141_1 crossref_primary_10_1080_14616688_2020_1759131 crossref_primary_10_1080_17441692_2015_1094110 crossref_primary_10_3389_fmicb_2021_795682 crossref_primary_10_1111_jch_12429 crossref_primary_10_1080_17441692_2020_1763420 crossref_primary_10_1155_2022_9366223 crossref_primary_10_3402_gha_v9_30306 crossref_primary_10_1186_s12936_015_0984_9 crossref_primary_10_1080_16549716_2017_1331538 crossref_primary_10_1186_s12879_015_1077_7 crossref_primary_10_1186_s12936_021_03804_0 crossref_primary_10_1016_S2352_3018_16_30089_3 crossref_primary_10_1002_EXP_20230139 crossref_primary_10_1186_s12992_018_0405_2 crossref_primary_10_2147_JBM_S343109 crossref_primary_10_1016_j_vaccine_2017_02_002 crossref_primary_10_1093_oxrep_grv024 crossref_primary_10_1371_journal_pone_0243617 crossref_primary_10_1371_journal_pcbi_1004093 crossref_primary_10_3389_fmicb_2022_1020029 crossref_primary_10_1186_s13011_019_0191_8 crossref_primary_10_1016_S0140_6736_21_02722_7 crossref_primary_10_1097_INF_0000000000002651 crossref_primary_10_1186_s12199_018_0728_x crossref_primary_10_1016_j_ejmech_2017_10_010 crossref_primary_10_1007_s10461_018_2029_1 crossref_primary_10_1017_S095026881800290X crossref_primary_10_1586_14760584_2016_1129904 crossref_primary_10_1038_emi_2016_86 crossref_primary_10_3389_fimmu_2019_02153 crossref_primary_10_1128_IAI_01120_15 crossref_primary_10_1155_2015_591237 crossref_primary_10_1136_bmjgh_2023_013349 crossref_primary_10_1016_S0140_6736_16_31012_1 crossref_primary_10_1182_blood_2014_11_610634 crossref_primary_10_1183_13993003_01454_2015 crossref_primary_10_1183_13993003_02352_2017 crossref_primary_10_1186_s12890_021_01740_y crossref_primary_10_1097_QAI_0000000000000963 crossref_primary_10_1016_j_plefa_2015_07_004 crossref_primary_10_1016_S0140_6736_14_61050_3 crossref_primary_10_1007_s10013_020_00433_z crossref_primary_10_1186_s12889_020_08988_9 crossref_primary_10_1155_2017_1613657 crossref_primary_10_4103_cmi_cmi_95_21 crossref_primary_10_1016_S0140_6736_14_61062_X crossref_primary_10_1093_eurpub_ckae031 crossref_primary_10_1186_s41182_017_0049_6 crossref_primary_10_1016_j_mric_2024_02_001 crossref_primary_10_3389_fimmu_2022_868305 crossref_primary_10_1371_journal_pone_0218781 crossref_primary_10_1128_AAC_01974_19 crossref_primary_10_7189_jogh_09_010434 crossref_primary_10_1186_s12903_025_05635_w crossref_primary_10_1186_s12981_022_00447_2 crossref_primary_10_3390_ph16030429 crossref_primary_10_3389_fmicb_2017_00708 crossref_primary_10_1073_pnas_1811380116 crossref_primary_10_1186_s12936_023_04467_9 crossref_primary_10_1097_INF_0000000000001219 crossref_primary_10_1186_s12889_023_15553_7 crossref_primary_10_1016_j_actatropica_2017_03_010 crossref_primary_10_3389_fimmu_2023_1135725 crossref_primary_10_1016_j_pt_2015_04_015 crossref_primary_10_1182_blood_2014_11_611707 crossref_primary_10_1016_S0140_6736_18_31891_9 crossref_primary_10_2989_16085906_2018_1467473 crossref_primary_10_3109_14397595_2015_1089973 crossref_primary_10_3390_mi7020032 crossref_primary_10_1016_j_cell_2016_06_023 crossref_primary_10_1016_S1473_3099_16_30325_5 crossref_primary_10_1016_S1473_3099_18_30625_X crossref_primary_10_1016_j_jiac_2020_04_003 crossref_primary_10_1111_dewb_12084 crossref_primary_10_1371_journal_pmed_1002879 crossref_primary_10_1371_journal_pcbi_1006480 crossref_primary_10_1038_srep28005 crossref_primary_10_1186_s13643_016_0241_5 crossref_primary_10_1016_j_omtn_2020_09_040 crossref_primary_10_3390_v7041578 crossref_primary_10_2478_arls_2023_0012 crossref_primary_10_1007_s13410_017_0599_5 crossref_primary_10_1080_09540121_2019_1612004 crossref_primary_10_1186_s12889_017_4071_8 crossref_primary_10_1371_journal_pone_0161647 crossref_primary_10_2147_JBM_S376476 crossref_primary_10_1186_s12916_015_0286_7 crossref_primary_10_1182_blood_2015_11_636464 crossref_primary_10_1186_s40249_020_00773_5 crossref_primary_10_1371_journal_pone_0216060 crossref_primary_10_1007_s40265_018_1043_y crossref_primary_10_1016_j_ijtb_2024_03_008 crossref_primary_10_1186_s12936_018_2590_0 crossref_primary_10_1515_ntrev_2016_0108 crossref_primary_10_1146_annurev_med_051214_024241 crossref_primary_10_1186_s12936_016_1394_3 crossref_primary_10_1007_s00420_024_02087_7 crossref_primary_10_1186_s40545_017_0103_0 crossref_primary_10_1080_20477724_2017_1309342 crossref_primary_10_1016_S1473_3099_15_00465_X crossref_primary_10_1177_0310057X19860984 crossref_primary_10_1007_s10096_015_2409_7 crossref_primary_10_3389_fgwh_2025_1464091 crossref_primary_10_1016_j_jadohealth_2017_09_030 crossref_primary_10_1111_nep_12750 crossref_primary_10_1186_s12936_015_0677_4 crossref_primary_10_1038_s41598_017_17814_z crossref_primary_10_3390_ijerph19095773 crossref_primary_10_1038_srep14325 crossref_primary_10_12688_wellcomeopenres_14769_1 crossref_primary_10_1371_journal_pone_0150970 crossref_primary_10_2217_imt_2018_0113 crossref_primary_10_12688_wellcomeopenres_14769_2 crossref_primary_10_12688_wellcomeopenres_15164_1 crossref_primary_10_1016_j_emc_2018_07_002 crossref_primary_10_1136_bmjgh_2021_007599 crossref_primary_10_1097_ANC_0000000000000568 crossref_primary_10_1186_s12879_017_2309_9 crossref_primary_10_3390_ijms231710001 crossref_primary_10_4236_health_2016_814151 crossref_primary_10_1371_journal_pone_0159449 crossref_primary_10_1016_S2213_2600_15_00543_3 crossref_primary_10_1186_s12879_025_11256_z crossref_primary_10_1186_s13071_018_2644_8 crossref_primary_10_1097_QAD_0000000000001768 crossref_primary_10_1007_s00134_019_05862_0 crossref_primary_10_1016_j_coi_2017_03_004 crossref_primary_10_1016_j_cdtm_2018_06_001 crossref_primary_10_1186_s12939_025_02378_6 crossref_primary_10_1097_QAD_0000000000002613 crossref_primary_10_1016_j_pt_2015_03_003 crossref_primary_10_1093_ofid_ofx246 crossref_primary_10_3201_eid2203_150977 crossref_primary_10_1371_journal_pone_0207339 crossref_primary_10_7759_cureus_8886 crossref_primary_10_1161_CIRCRESAHA_116_305697 crossref_primary_10_2147_COPD_S359873 crossref_primary_10_2217_cer_2016_0093 crossref_primary_10_1159_000369156 crossref_primary_10_1016_j_bmcl_2015_09_033 crossref_primary_10_1016_S0140_6736_17_31833_0 crossref_primary_10_1093_femsre_fuz005 crossref_primary_10_1056_NEJMp1510082 crossref_primary_10_1038_srep38874 crossref_primary_10_1016_j_jgar_2025_07_012 crossref_primary_10_1186_s12936_018_2295_4 crossref_primary_10_1080_03007995_2019_1700947 crossref_primary_10_2989_16085906_2019_1686033 crossref_primary_10_1186_s40249_022_01046_z crossref_primary_10_1371_journal_pmed_1002431 crossref_primary_10_1136_bmjgh_2021_005218 crossref_primary_10_1186_s12963_016_0106_0 crossref_primary_10_7759_cureus_11615 crossref_primary_10_1186_s12916_015_0518_x crossref_primary_10_1016_j_ejphar_2014_11_045 crossref_primary_10_1108_WJE_10_2016_0112 crossref_primary_10_1016_j_vaccine_2016_04_095 crossref_primary_10_7554_eLife_04395 crossref_primary_10_1016_j_vaccine_2016_06_040 crossref_primary_10_1186_s13031_021_00342_z crossref_primary_10_1002_iid3_306 crossref_primary_10_1186_s12864_019_5782_2 crossref_primary_10_1186_s12913_017_2512_9 crossref_primary_10_1016_j_atmosenv_2015_03_017 crossref_primary_10_1016_j_radcr_2021_08_070 crossref_primary_10_1111_nep_13135 crossref_primary_10_1186_s12936_020_03286_6 crossref_primary_10_1371_journal_pone_0122242 crossref_primary_10_1371_journal_pone_0285774 crossref_primary_10_1016_S1473_3099_15_00482_X crossref_primary_10_1080_09540121_2016_1258450 crossref_primary_10_1097_QAD_0000000000002870 crossref_primary_10_1136_bmjgh_2018_000797 crossref_primary_10_1038_s41598_021_84302_w crossref_primary_10_1371_journal_pone_0187102 crossref_primary_10_1016_j_sleh_2017_05_008 crossref_primary_10_1186_s12889_017_4836_0 crossref_primary_10_1186_s13690_023_01160_w crossref_primary_10_1016_S2352_3018_19_30196_1 crossref_primary_10_1016_j_tmaid_2022_102315 crossref_primary_10_1007_s11904_016_0326_8 crossref_primary_10_1186_s12963_025_00376_y crossref_primary_10_1093_ej_uead075 crossref_primary_10_1084_jem_20151468 crossref_primary_10_3389_fcimb_2016_00041 crossref_primary_10_1016_j_ijtb_2022_03_016 crossref_primary_10_1371_journal_pone_0148502 crossref_primary_10_1093_ije_dyy144 crossref_primary_10_1111_hiv_12535 crossref_primary_10_1016_S0140_6736_15_60692_4 crossref_primary_10_1371_journal_pone_0187592 crossref_primary_10_1007_s00268_021_06283_1 crossref_primary_10_1016_S1473_3099_15_70058_7 crossref_primary_10_1016_j_ijid_2014_11_017 crossref_primary_10_1186_s12936_018_2497_9 crossref_primary_10_21292_2075_1230_2018_96_7_46_49 crossref_primary_10_1016_j_jaging_2015_08_001 crossref_primary_10_1186_s12879_015_1009_6 crossref_primary_10_1016_S2215_0366_15_00508_8 crossref_primary_10_1186_s12936_019_2915_7 crossref_primary_10_1371_journal_pone_0247004 crossref_primary_10_1080_17512433_2019_1605903 crossref_primary_10_1155_2016_2850845 crossref_primary_10_1093_cid_civ265 crossref_primary_10_1016_S0140_6736_15_00401_8 crossref_primary_10_1007_s11886_022_01741_1 crossref_primary_10_1016_j_gheart_2015_12_015 crossref_primary_10_1093_inthealth_ihw027 crossref_primary_10_1155_2015_658421 crossref_primary_10_1371_journal_pone_0275827 crossref_primary_10_1007_s12639_021_01375_0 crossref_primary_10_1016_j_imlet_2018_06_005 crossref_primary_10_1007_s10389_017_0877_1 crossref_primary_10_1093_heapol_czx114 crossref_primary_10_1167_iovs_18_24102 crossref_primary_10_1186_s13059_014_0544_6 crossref_primary_10_1016_j_jinf_2017_08_010 crossref_primary_10_1136_tsaco_2016_000058 crossref_primary_10_4236_health_2017_93028 crossref_primary_10_1016_S2352_3018_15_00038_7 crossref_primary_10_1016_S0140_6736_20_31404_5 crossref_primary_10_1097_QAD_0000000000000488 crossref_primary_10_1097_QAD_0000000000000487 crossref_primary_10_1111_pbi_13110 crossref_primary_10_1016_j_aohep_2019_03_012 crossref_primary_10_1136_bmjgh_2017_000488 crossref_primary_10_5812_ircmj_17_4_2015_20277 crossref_primary_10_1002_acr_22948 crossref_primary_10_1016_j_jinf_2021_06_029 crossref_primary_10_1136_bmjgh_2019_001855 crossref_primary_10_1016_S1473_3099_15_70090_3 crossref_primary_10_1186_s12879_024_09050_4 crossref_primary_10_1186_s13071_024_06328_z crossref_primary_10_1186_s12916_014_0227_x crossref_primary_10_1164_rccm_201504_0781OC crossref_primary_10_4199_C00158ED1V01Y201710ISP078 crossref_primary_10_1097_QAI_0000000000000896 crossref_primary_10_1186_s40249_016_0209_7 crossref_primary_10_1016_j_ijid_2014_12_039 crossref_primary_10_1371_journal_pone_0180436 crossref_primary_10_1097_QAD_0000000000000495 crossref_primary_10_1186_s12992_018_0366_5 crossref_primary_10_1371_journal_ppat_1009382 crossref_primary_10_1155_2017_6429410 crossref_primary_10_1016_j_meegid_2019_05_019 crossref_primary_10_1128_AAC_02505_16 crossref_primary_10_1007_s10067_018_4304_y crossref_primary_10_1007_s00705_015_2583_z crossref_primary_10_1016_j_jiac_2016_05_004 crossref_primary_10_3892_mmr_2018_9073 crossref_primary_10_1097_INF_0000000000000710 crossref_primary_10_1016_S0140_6736_15_60626_2 crossref_primary_10_1038_srep20729 crossref_primary_10_1371_journal_pone_0264707 crossref_primary_10_1111_biom_13142 crossref_primary_10_1002_jia2_25219 crossref_primary_10_1016_j_eimce_2020_11_026 crossref_primary_10_3390_pharmaceutics13091405 crossref_primary_10_1097_QAD_0000000000002321 crossref_primary_10_1080_13697137_2019_1664457 crossref_primary_10_1186_s41479_016_0018_6 crossref_primary_10_1371_journal_pone_0188240 crossref_primary_10_1016_S2213_8587_16_30081_X crossref_primary_10_1186_s40249_015_0065_x crossref_primary_10_1186_s12936_015_0706_3 crossref_primary_10_1186_s12936_023_04502_9 crossref_primary_10_1186_s12916_015_0438_9 crossref_primary_10_1038_s41467_017_01944_z crossref_primary_10_3389_fmala_2024_1484359 crossref_primary_10_1186_s12936_016_1299_1 crossref_primary_10_1186_s12913_018_3124_8 crossref_primary_10_1097_OLQ_0000000000000222 crossref_primary_10_1186_s12936_020_03196_7 crossref_primary_10_1186_s42269_022_00953_3 |
| Cites_doi | 10.1186/1475-2875-12-18 10.1080/17441692.2013.845676 10.1016/0140-6736(92)91414-4 10.1111/j.1365-3156.2006.01603.x 10.1001/jama.2013.284692 10.1016/S0140-6736(11)60378-4 10.1097/QAD.0b013e32801424d2 10.2471/BLT.11.086280 10.1086/649842 10.1001/archinte.167.4.335 10.1016/S1473-3099(10)70096-7 10.1111/j.1759-5436.2010.00105.x 10.1016/S0140-6736(02)08595-1 10.1016/S0140-6736(10)61340-2 10.1007/s10461-013-0577-y 10.1080/02724936.1994.11747689 10.1371/journal.pone.0072616 10.1016/S0140-6736(12)61320-8 10.1016/S1472-9792(02)00058-6 10.1097/01.aids.0000299404.99033.bf 10.1016/S0140-6736(12)61321-X 10.1136/sti.2004.010199 10.1016/S0140-6736(11)60393-0 10.1016/j.worlddev.2006.08.003 10.1016/S0140-6736(04)17442-4 10.1016/0140-6736(91)93194-E 10.1093/heapol/czm045 10.1016/S0140-6736(10)60705-2 10.1186/1475-2875-10-378 10.1016/S0140-6736(10)61428-6 10.4269/ajtmh.2004.71.16 10.1093/qjmed/hcg059 10.1016/S0140-6736(12)61806-6 10.1371/journal.pmed.0050142 10.5588/ijtld.12.0959 10.1164/ajrccm/143.3.501 10.1097/01.aids.0000247572.95880.92 10.1371/journal.pmed.1000290 10.1097/00042560-199508000-00013 10.1093/infdis/jis635 10.1016/S0140-6736(04)17225-5 10.1146/annurev-publhealth-031912-114431 10.1136/sextrans-2013-051028 10.1016/S0140-6736(96)91073-9 10.1016/S2214-109X(13)70032-9 10.1016/S0140-6736(12)61690-0 10.1371/journal.pmed.1000241 10.1016/S0140-6736(02)08904-3 10.1016/S0140-6736(12)61680-8 10.1089/aid.2013.0092 10.1086/426827 10.1136/sextrans-2012-050640 10.1016/S0140-6736(07)61696-1 10.1371/journal.pone.0063476 10.1371/journal.pmed.1001477 10.1016/S0140-6736(12)61689-4 10.21149/spm.v55s1.5099 10.3760/cma.j.issn.0366-6999.20131502 10.2471/BLT.08.058453 10.1016/j.trstmh.2012.08.006 10.1016/S0140-6736(10)60232-2 10.1126/science.1195271 10.1016/S0140-6736(12)61322-1 10.1164/ajrccm/146.6.1439 10.1056/NEJMsa060247 10.1016/S0140-6736(13)62566-0 10.1097/QAD.0b013e32832b7dca 10.1371/journal.pone.0049526 10.1016/S0140-6736(12)61719-X 10.1046/j.1365-3156.1998.00255.x 10.1186/1478-7954-8-9 10.1056/NEJMoa1108789 10.1186/1475-2875-9-299 10.1080/00324728.1974.10405176 10.1056/NEJM200103153441108 10.1016/j.socscimed.2009.03.041 10.1371/journal.pntd.0002324 10.1016/S0140-6736(11)60888-X 10.1016/S0140-6736(12)60034-8 10.1016/S0140-6736(12)61323-3 10.1086/505877 10.1186/1475-2875-8-14 10.1371/journal.pone.0012242 10.1097/01.aids.0000299411.75269.e8 10.1016/S1473-3099(11)70031-7 10.1016/S0140-6736(10)61196-8 10.1016/S1473-3099(08)70130-0 10.1097/QAD.0b013e32835958ed 10.1097/00042560-199610010-00009 10.1097/QAD.0b013e3283514350 10.1371/journal.pmed.0050080 10.1016/S0140-6736(12)61766-8 10.1186/1478-7954-10-1 10.1016/j.drugpo.2013.08.004 10.1016/S0140-6736(95)90582-0 10.1016/S0140-6736(12)61899-6 10.3402/gha.v7.23695 10.1097/QAD.0000000000000085 10.1309/AJCP5XHDB1PNAEYT 10.1016/S0140-6736(12)60280-3 10.1016/S0140-6736(12)61728-0 10.1186/1741-7015-12-5 10.1016/S2214-109X(13)70044-5 10.1097/QAD.0b013e3283121ca9 10.1016/S0140-6736(08)61654-2 10.1016/S0140-6736(10)61255-X 10.1186/1478-7547-4-20 10.1377/hlthaff.2013.1432 10.1093/ije/dym073 10.7448/IAS.16.4.18751 10.1155/2013/828939 10.1016/S0140-6736(12)60560-1 10.1016/S0140-6736(12)61729-2 10.1371/journal.pone.0026892 10.1136/bmj.38251.658229.55 10.1136/jech.54.1.64 10.1016/S0140-6736(08)61311-2 10.1016/S0140-6736(12)62134-5 |
| ContentType | Journal Article |
| Copyright | 2014 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright © 2014 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited Sep 13, 2014 Wageningen University & Research |
| Copyright_xml | – notice: 2014 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2014 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited Sep 13, 2014 – notice: Wageningen University & Research |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7X8 F1W H95 H97 L.G 5PM ADTPV AOWAS DF2 F1U D8T ZZAVC QVL |
| DOI | 10.1016/S0140-6736(14)60844-8 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection ProQuest Public Health Database Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional ProQuest Biological Science Collection Consumer Health Database Health & Medical Collection (Alumni Edition) Health Management Database PML(ProQuest Medical Library) Psychology Database Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database (ProQuest) Research Library (Corporate) ProQuest Nursing and Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic ASFA: Aquatic Sciences and Fisheries Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality Aquatic Science & Fisheries Abstracts (ASFA) Professional PubMed Central (Full Participant titles) SwePub SwePub Articles SWEPUB Uppsala universitet SWEPUB Göteborgs universitet SWEPUB Freely available online SwePub Articles full text NARCIS:Publications |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic Aquatic Science & Fisheries Abstracts (ASFA) Professional ASFA: Aquatic Sciences and Fisheries Abstracts Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Aquatic Science & Fisheries Abstracts (ASFA) Professional ProQuest One Psychology |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1474-547X |
| EndPage | 1070 |
| ExternalDocumentID | oai_library_wur_nl_wurpubs_480400 oai_swepub_ki_se_520039 oai_gup_ub_gu_se_203989 oai_DiVA_org_uu_229029 oai_DiVA_org_du_21324 PMC4202387 3492119011 25059949 28750108 10_1016_S0140_6736_14_60844_8 S0140673614608448 1_s2_0_S0140673614608448 |
| Genre | Multicenter Study Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GeographicLocations | Europe Africa Latin America |
| GeographicLocations_xml | – name: Africa – name: Latin America – name: Europe |
| GrantInformation | Bill & Melinda Gates Foundation. |
| GrantInformation_xml | – fundername: NIA NIH HHS grantid: U01 AG018947 – fundername: NCATS NIH HHS grantid: KL2 TR001088 – fundername: Wellcome Trust grantid: 091758 – fundername: NCI NIH HHS grantid: U10 CA149950 – fundername: NIAMS NIH HHS grantid: P50 AR060772 – fundername: Medical Research Council grantid: MC_U147585824 – fundername: Wellcome Trust grantid: 099876 – fundername: NIDA NIH HHS grantid: DA R01 003574 – fundername: NCATS NIH HHS grantid: UL1 TR001086 – fundername: Department of Health grantid: CDF-2013-06-012 |
| GroupedDBID | --- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AAQQT AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHHHB AHMBA AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ R2- ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UQL UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD .GJ 04C 3EH 3O- 3V. 41~ 88A 8WZ A6W AACTN AAEJM AAKAS AAQXK AAYOK ABDBF ABTAH ABWVN ACRPL ACRZS ACUHS ADMUD ADNMO ADZCM AFCTW AFFNX AFKWA AHQJS AJJEV AJOXV AKVCP ALIPV AMFUW ARTTT ASPBG AVWKF AZFZN D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H M0L M41 MVM OVD PKN Q~Q RIG SDF SV3 TEORI TH9 UHU WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 ABLVK ABYKQ AHPSJ AJBFU XFK ZA5 9DU AAYXX ADXHL AFFHD AGQPQ AIGII CITATION IQODW AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7QL 7QP 7TK 7U7 7U9 7XB 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 F1W H95 H97 L.G 5PM ADTPV AOWAS DF2 F1U D8T ZZAVC - 08R 0R 1AW 1P 41 55 AALRV AASXA ABFLS ACDCL ACJLH ADBIT AFRUD BBAFP CO FO G0 G8K GJ HZ K M OO PAF QVL STF UNR YXB |
| ID | FETCH-LOGICAL-c1047t-f5c80a1a2938571b22d85743ca7f2c7d0eb2127736aaba8296aa8bba81b017313 |
| IEDL.DBID | 7X7 |
| ISICitedReferencesCount | 652 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000341679700032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0140-6736 1474-547X |
| IngestDate | Fri Feb 05 18:08:32 EST 2021 Tue Nov 25 03:25:35 EST 2025 Tue Nov 04 16:53:46 EST 2025 Tue Nov 04 17:24:52 EST 2025 Tue Nov 04 16:10:16 EST 2025 Tue Nov 04 01:57:12 EST 2025 Tue Oct 07 09:24:22 EDT 2025 Sun Nov 09 11:59:40 EST 2025 Sat Nov 29 14:24:27 EST 2025 Mon Jul 21 06:05:57 EDT 2025 Wed Apr 02 07:14:57 EDT 2025 Sat Nov 29 07:24:31 EST 2025 Tue Nov 18 22:12:37 EST 2025 Fri Feb 23 02:30:16 EST 2024 Sun Feb 23 10:19:13 EST 2025 Tue Oct 14 19:29:42 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 9947 |
| Keywords | Immunopathology Protozoal disease Statistical analysis Malaria Mortality Retroviridae 1990 AIDS Mycobacterial infection Parasitosis Regional Immune deficiency Lentivirus Epidemiology Morbidity Incidence Infection Virus Medicine Tuberculosis Viral disease Bacteriosis Human immunodeficiency virus |
| Language | English |
| License | CC BY 4.0 Copyright © 2014 Elsevier Ltd. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c1047t-f5c80a1a2938571b22d85743ca7f2c7d0eb2127736aaba8296aa8bba81b017313 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Authors listed alphabetically Joint senior authors Contributors: CJLM, ADL, and TV prepared the first draft. CJLM, KFO, CG, SSL, TMW, DAR, EAD, NG, RMB, JCB, HCD, LD, JAS, DEP, TDF, BKP, EKJ, MSC, ADL, and TV finalised the draft based on comments from other authors and reviewer feedback. CJLM, SSL, and TV had the idea for the study and provided overall guidance. CJLM, KFO, CG, SSL, TMW, DAR, EAD, NG, HW, MN, DD, KRH, KF, DEP, TDF, ADF, and TV did all modeling. CJLM, KFO, CG, SSL, TMW, DAR, EAD, NG, RMB, HW, HCD, DD, DEP, ADF, and TV did the statistical analysis of model results. All other authors provided data, developed models, reviewed results, initiated modeling infrastructure, and reviewed the paper. |
| OpenAccessLink | http://kipublications.ki.se/Default.aspx?queryparsed=id:129737235 |
| PMID | 25059949 |
| PQID | 1622597602 |
| PQPubID | 40246 |
| PageCount | 66 |
| ParticipantIDs | wageningen_narcis_oai_library_wur_nl_wurpubs_480400 swepub_primary_oai_swepub_ki_se_520039 swepub_primary_oai_gup_ub_gu_se_203989 swepub_primary_oai_DiVA_org_uu_229029 swepub_primary_oai_DiVA_org_du_21324 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4202387 proquest_miscellaneous_1635023000 proquest_miscellaneous_1562441285 proquest_journals_1622597602 pubmed_primary_25059949 pascalfrancis_primary_28750108 crossref_citationtrail_10_1016_S0140_6736_14_60844_8 crossref_primary_10_1016_S0140_6736_14_60844_8 elsevier_sciencedirect_doi_10_1016_S0140_6736_14_60844_8 elsevier_clinicalkeyesjournals_1_s2_0_S0140673614608448 elsevier_clinicalkey_doi_10_1016_S0140_6736_14_60844_8 |
| ProviderPackageCode | QVL |
| PublicationCentury | 2000 |
| PublicationDate | 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – year: 2014 text: 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | Kidlington |
| PublicationPlace_xml | – name: Kidlington – name: England – name: London |
| PublicationTitle | The Lancet (British edition) |
| PublicationTitleAlternate | Lancet |
| PublicationYear | 2014 |
| Publisher | Elsevier Ltd Elsevier Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier – name: Elsevier Limited |
| References | Hallett, Zaba, Todd (bib56) 2008; 5 Naghavi, Makela, Foreman, O'Brien, Pourmalek, Lozano (bib85) 2010; 8 Shah, Dhariwal, Sonal, Gunasekar, Dye, Cibulskis (bib145) 2011; 377 Houben, Glynn, Mboma (bib91) 2012; 26 Flateau, Le Loup, Pialoux (bib117) 2011; 11 Lynch, Korenromp, Eisele (bib96) 2012; 380 Giglioli (bib154) 1972; 46 Alleyne, Binagwaho, Haines (bib19) 2013; 381 Snow, Okiro, Gething, Atun, Hay (bib7) 2010; 376 bib37 Steketee, Campbell (bib140) 2010; 9 Reyburn, Mbatia, Drakeley (bib147) 2004; 329 Hewitt, Steketee, Mwapasa, Whitworth, French (bib116) 2006; 20 Byass, de Courten, Graham (bib95) 2013; 10 Mpimbaza, Filler, Katureebe (bib102) 2011; 6 bib29 Hecht, Stover, Bollinger, Muhib, Case, de Ferranti (bib5) 2010; 376 Atun, Raviglione, Marais, Zumla (bib14) 2010; 376 White, Dondorp, Faiz, Mishra, Hien (bib100) 2012; 380 Snow, Armstrong, Forster (bib101) 1992; 340 Badri, Wilson, Wood (bib93) 2002; 359 Freguja, Gianesin, Del Bianco (bib114) 2012; 26 Gray (bib153) 1974; 28 Ceesay, Casals-Pascual, Erskine (bib158) 2008; 372 Mehra, Cossrow, Kambili, Underwood, Makkar, Potluri (bib137) 2013; 17 (accessed March 5, 2014). Verguet, Lim, Murray, Gakidou, Salomon (bib59) 2013; 207 Snow RW, Newton CRJC. The public health burden of Ng, Freeman, Fleming (bib77) 2014; 311 Jackson, Chopra, Doherty (bib122) 2007; 21 Keizer, Langendam, van Deutekom, Coutinho, van Ameijden (bib89) 2000; 54 Setel, Whiting, Hemed (bib105) 2006; 11 Dabis, Bequet, Ekouevi (bib123) 2005; 19 (bib12) 2013 Salomon, Wang, Freeman (bib45) 2012; 380 Bates, Khalakdina, Pai, Chang, Lessa, Smith (bib131) 2007; 167 Allen, Batungwanayo, Kerlikowske (bib87) 1992; 146 (bib32) 2012 Simbayi, Shisana, Rehle (bib80) Papworth, Ceesay, An (bib62) 2013; 16 Sajadi, Mirzazadeh, Navadeh (bib69) 2013; 89 Clemens, Kenny, Moss (bib13) 2007; 35 Murray, Vos, Lozano (bib47) 2012; 380 Prüss-Ustün, Wolf, Driscoll, Degenhardt, Neira, Calleja (bib72) 2013; 8 bib39 Vandemoortele, Delamonica (bib28) 2010; 41 Chandramohan, Maude, Rodrigues, Hayes (bib106) 1998; 3 Gething, Patil, Smith (bib108) 2011; 10 Stover, Brown, Marston (bib38) 2012; 88 Dieleman, Graves, Templin (bib109) 2014; 33 Freedberg, Losina, Weinstein (bib126) 2001; 344 Leroy, Msellati, Lepage (bib90) 1995; 9 Murray, Rosenfeld, Lim (bib94) 2012; 379 (bib20) 2013; 15 Ruan, Liang, Zhu (bib64) 2013; 44 Makani, Matuja, Liyombo, Snow, Marsh, Warrell (bib149) 2003; 96 Shah, Kumar, Valecha (bib99) 2012; 380 Espinal (bib133) 2003; 83 Creese, Floyd, Alban, Guinness (bib3) 2002; 359 The GBD 2013 Collaboration. Global, Regional, and National Levels of Age-Specific Mortality and 266 Causes of Death, 1990–2013: A Systematic Analysis. In preparation. Salomon, Vos, Hogan (bib44) 2012; 380 Pretorius, Menzies, Chindelevitch (bib40) 2014; 28 Brown, Grassly, Garnett, Stanecki (bib53) 2006; 82 bib136 Mathers, Degenhardt, Ali (bib70) 2010; 375 Shiffman (bib27) 2008; 23 Murray, Ezzati, Flaxman (bib42) 2012; 380 Vos, Flaxman, Naghavi (bib46) 2012; 380 Snow, Korenromp, Gouws (bib150) 2004; 71 Li, Wang, Lin (bib68) 2014; 127 malaria in Africa: deriving the numbers. Washington DC: The Disease Control Priorities Project (DCPP) Working Paper Number 11, 2003: 75. Wang, Dwyer-Lindgren, Lofgren (bib43) 2012; 380 bib60 Lönnroth, Jaramillo, Williams, Dye, Raviglione (bib132) 2009; 68 Korenromp, Hosseini, Newman, Cibulskis (bib8) 2013; 12 Waage, Banerji, Campbell (bib10) 2010; 376 (bib82) 2013 The GBD 2013 Collaboration. Global, Regional, and National Burden of Disease for 322 Disease and Injuries and 68 Risk Factors, 1990-2013: A Systematic Analysis. In preparation. Ferreira, Ferrazoli, Palaci (bib92) 1996; 13 D'Alessandro, Olaleye, McGuire (bib155) 1995; 345 Fehling, Nelson, Venkatapuram (bib16) 2013; 8 (bib31) 2011 Zhao, Xu, Wang (bib135) 2012; 366 (bib33) 2013 Braun, Badi, Ryder (bib88) 1991; 143 Todd, De Francisco, O'Dempsey, Greenwood (bib104) 1994; 14 O'Meara, Mangeni, Steketee, Greenwood (bib141) 2010; 10 Ghys, Zaba, Prins (bib55) 2007; 21 Dye, Lönnroth, Jaramillo, Williams, Raviglione (bib81) 2009; 87 (bib110) 2013 Vitoria, Granich, Gilks (bib18) 2009; 131 Zignol, Hosseini, Wright (bib134) 2006; 194 Otten, Aregawi, Were (bib139) 2009; 8 bib78 bib79 Murray, Ezzati, Flaxman (bib41) 2012; 380 (bib83) 2011 Herbeck, Gottlieb, Winkler (bib113) 2010; 201 Alliance (bib24) (bib143) 2012 Miller, Buckingham, Sánchez-Domínguez, Morales-Miranda, Paz-Bailey (bib66) 2013; 55 Donnell, Baeten, Kiarie (bib120) 2010; 375 (bib30) 2012 Decker, Wirtz, Moguilnyi (bib65) 2014; 18 Ghys, Brown, Grassly (bib52) 2004; 80 Birnbaum, Murray, Lozano (bib75) 2011; 89 (bib61) 2004 Wagstaff (bib36) 2004 McGowan, Cahn, Gotuzzo (bib57) 2007; 36 (bib73) 2005 Ceesay, Casals-Pascual, Nwakanma (bib159) 2010; 5 WHO Global Task Force on TB Impact Measurement. National TB prevalence surveys. 2014. Nash, Katyal, Brinkhof (bib58) 2008; 22 Shah (bib144) 2012; 135 Lozano, Naghavi, Foreman (bib74) 2012; 380 Freguja, Gianesin, Zanchetta, De Rossi (bib115) 2012; 35 Degenhardt, Mathers, Wirtz (bib129) 2014; 25 Shanks, Hay, Bradley (bib152) 2008; 8 Mermin, Lule, Ekwaru (bib124) 2004; 364 Lomazzi, Borisch, Laaser (bib15) 2014; 7 Noor, Kinyoki, Mundia (bib142) 2014 Attia, Egger, Müller, Zwahlen, Low (bib121) 2009; 23 Goldie, Yazdanpanah, Losina (bib127) 2006; 355 Institute for Health Metrics and Evaluation. Financing Global Health 2013: Transition in an Age of Austerity. Seattle, WA, IHME, 2013. 2011. Murray, Lozano, Flaxman (bib107) 2014; 12 Abegunde, Mathers, Adam, Ortegon, Strong (bib26) 2007; 370 Sonnenberg, Glynn, Fielding, Murray, Godfrey-Faussett, Shearer (bib86) 2005; 191 Darby, Ewart, Giangrande, Spooner, Rizza (bib157) 1996; 347 Chintu, Bhat, Walker (bib125) 2004; 364 Waddington, Martin, Walford (bib9) 2005 Lim, Vos, Flaxman (bib48) 2012; 380 Bates, O'Grady, Mudenda, Shibemba, Zumla (bib97) 2012; 380 Nykanen, Tamaona, Cullinan, Van Oosterzee, Ashorn (bib103) 1995; 72 Alonso, Lindsay, Armstrong (bib156) 1991; 337 Vassall, Remme (bib4) 2013; 1 Pereyra, Jia (bib112) 2010; 330 Umunyana (bib118) 2014 Dye, Glaziou, Floyd, Raviglione (bib11) 2013; 34 Mathers, Degenhardt, Phillips (bib71) 2008; 372 Stop (bib34) 2012 Todd, Glynn, Marston (bib54) 2007; 21 Hay, Okiro, Gething (bib163) 2010; 7 Ki-moon B. Secretary-General's message on World Malaria Day. Foreman, Lozano, Lopez, Murray (bib76) 2012; 10 Roll Back Malaria. Malaria Funding & Resource Utilization: The First Decade of Roll Back Malaria. 2010. Snow, Guerra, Mutheu, Hay (bib6) 2008; 5 The GBD 2013 Collaboration. Global, Regional, and National Prevalence and Disability for 318 Disease and Injuries and Their 2,435 Sequelae, 1990-2013: A Systematic Analysis. In preparation. Chambers (bib98) 2012; 379 Yang, Jiao, Wang (bib111) 2012; 7 Stuckler, Basu, McKee (bib17) 2010; 7 Bautista-Arredondo, Colchero, Romero, Conde-Glez, Sosa-Rubí (bib63) 2013; 8 bib23 Cleary, McIntyre, Boulle (bib128) 2006; 4 bib21 Nadjm, Mtove, Amos (bib148) 2012; 106 bib22 Crump, Morrissey, Nicholson (bib146) 2013; 7 (bib119) 2007 Scott, Berkley, Mwangi (bib151) 2011; 378 Floyd, Fitzpatrick, Pantoja, Raviglione (bib2) 2013; 1 Beaglehole, Bonita, Horton (bib25) 2011; 377 Mason, Ketende, Peitzmeier (bib67) 2013; 29 bib162 bib160 Verguet (10.1016/S0140-6736(14)60844-8_bib59) 2013; 207 Murray (10.1016/S0140-6736(14)60844-8_bib41) 2012; 380 Steketee (10.1016/S0140-6736(14)60844-8_bib140) 2010; 9 Ghys (10.1016/S0140-6736(14)60844-8_bib52) 2004; 80 Bates (10.1016/S0140-6736(14)60844-8_bib97) 2012; 380 Ferreira (10.1016/S0140-6736(14)60844-8_bib92) 1996; 13 (10.1016/S0140-6736(14)60844-8_bib12) 2013 Alliance (10.1016/S0140-6736(14)60844-8_bib24) Creese (10.1016/S0140-6736(14)60844-8_bib3) 2002; 359 Flateau (10.1016/S0140-6736(14)60844-8_bib117) 2011; 11 Beaglehole (10.1016/S0140-6736(14)60844-8_bib25) 2011; 377 Stover (10.1016/S0140-6736(14)60844-8_bib38) 2012; 88 Murray (10.1016/S0140-6736(14)60844-8_bib107) 2014; 12 Herbeck (10.1016/S0140-6736(14)60844-8_bib113) 2010; 201 Zignol (10.1016/S0140-6736(14)60844-8_bib134) 2006; 194 Vassall (10.1016/S0140-6736(14)60844-8_bib4) 2013; 1 Papworth (10.1016/S0140-6736(14)60844-8_bib62) 2013; 16 10.1016/S0140-6736(14)60844-8_bib164 Shah (10.1016/S0140-6736(14)60844-8_bib145) 2011; 377 Snow (10.1016/S0140-6736(14)60844-8_bib150) 2004; 71 Crump (10.1016/S0140-6736(14)60844-8_bib146) 2013; 7 Yang (10.1016/S0140-6736(14)60844-8_bib111) 2012; 7 Salomon (10.1016/S0140-6736(14)60844-8_bib45) 2012; 380 Decker (10.1016/S0140-6736(14)60844-8_bib65) 2014; 18 Murray (10.1016/S0140-6736(14)60844-8_bib94) 2012; 379 Makani (10.1016/S0140-6736(14)60844-8_bib149) 2003; 96 Byass (10.1016/S0140-6736(14)60844-8_bib95) 2013; 10 Dabis (10.1016/S0140-6736(14)60844-8_bib123) 2005; 19 Chambers (10.1016/S0140-6736(14)60844-8_bib98) 2012; 379 Korenromp (10.1016/S0140-6736(14)60844-8_bib8) 2013; 12 Snow (10.1016/S0140-6736(14)60844-8_bib101) 1992; 340 Giglioli (10.1016/S0140-6736(14)60844-8_bib154) 1972; 46 (10.1016/S0140-6736(14)60844-8_bib73) 2005 Braun (10.1016/S0140-6736(14)60844-8_bib88) 1991; 143 Alonso (10.1016/S0140-6736(14)60844-8_bib156) 1991; 337 Darby (10.1016/S0140-6736(14)60844-8_bib157) 1996; 347 Floyd (10.1016/S0140-6736(14)60844-8_bib2) 2013; 1 Vandemoortele (10.1016/S0140-6736(14)60844-8_bib28) 2010; 41 Setel (10.1016/S0140-6736(14)60844-8_bib105) 2006; 11 Foreman (10.1016/S0140-6736(14)60844-8_bib76) 2012; 10 Dieleman (10.1016/S0140-6736(14)60844-8_bib109) 2014; 33 Attia (10.1016/S0140-6736(14)60844-8_bib121) 2009; 23 Freedberg (10.1016/S0140-6736(14)60844-8_bib126) 2001; 344 Mpimbaza (10.1016/S0140-6736(14)60844-8_bib102) 2011; 6 Miller (10.1016/S0140-6736(14)60844-8_bib66) 2013; 55 Nadjm (10.1016/S0140-6736(14)60844-8_bib148) 2012; 106 Narasimhan (10.1016/S0140-6736(14)60844-8_bib130) 2013; 2013 10.1016/S0140-6736(14)60844-8_bib35 Snow (10.1016/S0140-6736(14)60844-8_bib6) 2008; 5 Ghys (10.1016/S0140-6736(14)60844-8_bib55) 2007; 21 Birnbaum (10.1016/S0140-6736(14)60844-8_bib75) 2011; 89 (10.1016/S0140-6736(14)60844-8_bib83) 2011 Dye (10.1016/S0140-6736(14)60844-8_bib11) 2013; 34 Lomazzi (10.1016/S0140-6736(14)60844-8_bib15) 2014; 7 Fehling (10.1016/S0140-6736(14)60844-8_bib16) 2013; 8 Hallett (10.1016/S0140-6736(14)60844-8_bib56) 2008; 5 Mason (10.1016/S0140-6736(14)60844-8_bib67) 2013; 29 Bates (10.1016/S0140-6736(14)60844-8_bib131) 2007; 167 Dye (10.1016/S0140-6736(14)60844-8_bib81) 2009; 87 Houben (10.1016/S0140-6736(14)60844-8_bib91) 2012; 26 Lynch (10.1016/S0140-6736(14)60844-8_bib96) 2012; 380 Shiffman (10.1016/S0140-6736(14)60844-8_bib27) 2008; 23 Prüss-Ustün (10.1016/S0140-6736(14)60844-8_bib72) 2013; 8 Shah (10.1016/S0140-6736(14)60844-8_bib99) 2012; 380 10.1016/S0140-6736(14)60844-8_bib49 (10.1016/S0140-6736(14)60844-8_bib20) 2013; 15 Reyburn (10.1016/S0140-6736(14)60844-8_bib147) 2004; 329 Ceesay (10.1016/S0140-6736(14)60844-8_bib159) 2010; 5 Snow (10.1016/S0140-6736(14)60844-8_bib7) 2010; 376 Simbayi (10.1016/S0140-6736(14)60844-8_bib80) Ruan (10.1016/S0140-6736(14)60844-8_bib64) 2013; 44 Zhao (10.1016/S0140-6736(14)60844-8_bib135) 2012; 366 Vitoria (10.1016/S0140-6736(14)60844-8_bib18) 2009; 131 McGowan (10.1016/S0140-6736(14)60844-8_bib57) 2007; 36 Keizer (10.1016/S0140-6736(14)60844-8_bib89) 2000; 54 Chintu (10.1016/S0140-6736(14)60844-8_bib125) 2004; 364 Clemens (10.1016/S0140-6736(14)60844-8_bib13) 2007; 35 O'Meara (10.1016/S0140-6736(14)60844-8_bib141) 2010; 10 (10.1016/S0140-6736(14)60844-8_bib61) 2004 10.1016/S0140-6736(14)60844-8_bib50 Todd (10.1016/S0140-6736(14)60844-8_bib104) 1994; 14 Wang (10.1016/S0140-6736(14)60844-8_bib43) 2012; 380 Sajadi (10.1016/S0140-6736(14)60844-8_bib69) 2013; 89 Liu (10.1016/S0140-6736(14)60844-8_bib161) 2012; 379 10.1016/S0140-6736(14)60844-8_bib51 Badri (10.1016/S0140-6736(14)60844-8_bib93) 2002; 359 10.1016/S0140-6736(14)60844-8_bib138 Allen (10.1016/S0140-6736(14)60844-8_bib87) 1992; 146 Waage (10.1016/S0140-6736(14)60844-8_bib10) 2010; 376 Mathers (10.1016/S0140-6736(14)60844-8_bib70) 2010; 375 Freguja (10.1016/S0140-6736(14)60844-8_bib115) 2012; 35 Freguja (10.1016/S0140-6736(14)60844-8_bib114) 2012; 26 Noor (10.1016/S0140-6736(14)60844-8_bib142) 2014 Gray (10.1016/S0140-6736(14)60844-8_bib153) 1974; 28 Ceesay (10.1016/S0140-6736(14)60844-8_bib158) 2008; 372 Naghavi (10.1016/S0140-6736(14)60844-8_bib85) 2010; 8 Cleary (10.1016/S0140-6736(14)60844-8_bib128) 2006; 4 Scott (10.1016/S0140-6736(14)60844-8_bib151) 2011; 378 Ng (10.1016/S0140-6736(14)60844-8_bib77) 2014; 311 Mermin (10.1016/S0140-6736(14)60844-8_bib124) 2004; 364 Brown (10.1016/S0140-6736(14)60844-8_bib53) 2006; 82 Otten (10.1016/S0140-6736(14)60844-8_bib139) 2009; 8 Stop (10.1016/S0140-6736(14)60844-8_bib34) 2012 10.1016/S0140-6736(14)60844-8_bib1 Pretorius (10.1016/S0140-6736(14)60844-8_bib40) 2014; 28 Murray (10.1016/S0140-6736(14)60844-8_bib42) 2012; 380 Vos (10.1016/S0140-6736(14)60844-8_bib46) 2012; 380 Pereyra (10.1016/S0140-6736(14)60844-8_bib112) 2010; 330 Shanks (10.1016/S0140-6736(14)60844-8_bib152) 2008; 8 Donnell (10.1016/S0140-6736(14)60844-8_bib120) 2010; 375 Lozano (10.1016/S0140-6736(14)60844-8_bib74) 2012; 380 Li (10.1016/S0140-6736(14)60844-8_bib68) 2014; 127 Salomon (10.1016/S0140-6736(14)60844-8_bib44) 2012; 380 Mehra (10.1016/S0140-6736(14)60844-8_bib137) 2013; 17 Degenhardt (10.1016/S0140-6736(14)60844-8_bib129) 2014; 25 Lim (10.1016/S0140-6736(14)60844-8_bib48) 2012; 380 Hecht (10.1016/S0140-6736(14)60844-8_bib5) 2010; 376 Wagstaff (10.1016/S0140-6736(14)60844-8_bib36) 2004 D'Alessandro (10.1016/S0140-6736(14)60844-8_bib155) 1995; 345 Atun (10.1016/S0140-6736(14)60844-8_bib14) 2010; 376 Nash (10.1016/S0140-6736(14)60844-8_bib58) 2008; 22 Abegunde (10.1016/S0140-6736(14)60844-8_bib26) 2007; 370 Mathers (10.1016/S0140-6736(14)60844-8_bib71) 2008; 372 Jackson (10.1016/S0140-6736(14)60844-8_bib122) 2007; 21 Goldie (10.1016/S0140-6736(14)60844-8_bib127) 2006; 355 Hay (10.1016/S0140-6736(14)60844-8_bib163) 2010; 7 Nykanen (10.1016/S0140-6736(14)60844-8_bib103) 1995; 72 Gething (10.1016/S0140-6736(14)60844-8_bib108) 2011; 10 Waddington (10.1016/S0140-6736(14)60844-8_bib9) 2005 Sonnenberg (10.1016/S0140-6736(14)60844-8_bib86) 2005; 191 Shah (10.1016/S0140-6736(14)60844-8_bib144) 2012; 135 Lönnroth (10.1016/S0140-6736(14)60844-8_bib132) 2009; 68 10.1016/S0140-6736(14)60844-8_bib84 Espinal (10.1016/S0140-6736(14)60844-8_bib133) 2003; 83 Hewitt (10.1016/S0140-6736(14)60844-8_bib116) 2006; 20 White (10.1016/S0140-6736(14)60844-8_bib100) 2012; 380 Alleyne (10.1016/S0140-6736(14)60844-8_bib19) 2013; 381 Murray (10.1016/S0140-6736(14)60844-8_bib47) 2012; 380 Umunyana (10.1016/S0140-6736(14)60844-8_bib118) Chandramohan (10.1016/S0140-6736(14)60844-8_bib106) 1998; 3 Leroy (10.1016/S0140-6736(14)60844-8_bib90) 1995; 9 Todd (10.1016/S0140-6736(14)60844-8_bib54) 2007; 21 Stuckler (10.1016/S0140-6736(14)60844-8_bib17) 2010; 7 Bautista-Arredondo (10.1016/S0140-6736(14)60844-8_bib63) 2013; 8 25845784 - Lancet. 2015 Mar 28;385(9974):1177. doi: 10.1016/S0140-6736(15)60626-2. 25933281 - Lancet. 2015 Apr 18;385(9977):1510. doi: 10.1016/S0140-6736(15)60753-X. Lancet. 2014 Oct 25;384(9953):1504 25073423 - Lancet. 2014 Sep 13;384(9947):935-6. doi: 10.1016/S0140-6736(14)61222-8. 36661238 - Br J Haematol. 2023 May;201(4):599-601. doi: 10.1111/bjh.18651. 25059946 - Lancet. 2014 Sep 13;384(9947):937-8. doi: 10.1016/S0140-6736(14)61062-X. Lancet. 2014 Sep 13;384(9947):956 |
| References_xml | – volume: 34 start-page: 271 year: 2013 end-page: 286 ident: bib11 article-title: Prospects for tuberculosis elimination publication-title: Annu Rev Public Health – ident: bib21 article-title: WEF. From Burden to ‘Best Buys’: Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries. World Economic Forum, 2011 – volume: 380 start-page: 2197 year: 2012 end-page: 2223 ident: bib47 article-title: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – ident: bib60 article-title: Global Report: UNAIDS report on the global AIDS epidemic 2013. Joint United Nations Programme on HIV/AIDS, 2013 – volume: 72 start-page: 731 year: 1995 end-page: 734 ident: bib103 article-title: Verbal autopsy as a technique to establish causes of infant and child mortality publication-title: East Afr Med J – volume: 33 start-page: 878 year: 2014 end-page: 886 ident: bib109 article-title: Global health development assistance remained steady in 2013 but did not align with recipients' disease burden publication-title: Health Aff (Millwood) – reference: Institute for Health Metrics and Evaluation. Financing Global Health 2013: Transition in an Age of Austerity. Seattle, WA, IHME, 2013. – volume: 372 start-page: 1545 year: 2008 end-page: 1554 ident: bib158 article-title: Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis publication-title: Lancet – ident: bib29 article-title: 2011-2015 Strategy: Getting to Zero. Joint United Nations Programme on HIV/AIDS, 2010 – year: 2011 ident: bib31 article-title: UKAID. Towards zero infections: The UK's position paper on HIV in the developing world – volume: 3 start-page: 436 year: 1998 end-page: 446 ident: bib106 article-title: Verbal autopsies for adult deaths: their development and validation in a multicentre study publication-title: Trop Med Int Health – volume: 28 start-page: S25 year: 2014 end-page: S34 ident: bib40 article-title: The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models publication-title: AIDS – volume: 7 start-page: 23695 year: 2014 ident: bib15 article-title: The Millennium Development Goals: experiences, achievements and what's next publication-title: Glob Health Action – volume: 376 start-page: 940 year: 2010 end-page: 941 ident: bib14 article-title: Tuberculosis control is crucial to achieve the MDGs publication-title: Lancet – volume: 12 start-page: 18 year: 2013 ident: bib8 article-title: Progress towards malaria control targets in relation to national malaria programme funding publication-title: Malar J – volume: 194 start-page: 479 year: 2006 end-page: 485 ident: bib134 article-title: Global incidence of multidrug-resistant tuberculosis publication-title: J Infect Dis – volume: 28 start-page: 205 year: 1974 end-page: 229 ident: bib153 article-title: The decline of mortality in Ceylon and the demographic effects of malaria control publication-title: Popul Stud (Camb) – volume: 379 start-page: 707 year: 2012 end-page: 708 ident: bib98 article-title: UN Envoy's response to estimates of global malaria mortality publication-title: Lancet – volume: 54 start-page: 64 year: 2000 end-page: 68 ident: bib89 article-title: How does tuberculosis relate to HIV positive and HIV negative drug users? publication-title: J Epidemiol Community Health – ident: bib80 article-title: South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Human Sciences Resource Council, 2014 – volume: 364 start-page: 1865 year: 2004 end-page: 1871 ident: bib125 article-title: Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial publication-title: Lancet – volume: 135 start-page: 270 year: 2012 end-page: 272 ident: bib144 article-title: Defining & counting malaria deaths publication-title: Indian J Med Res – volume: 380 start-page: 2095 year: 2012 end-page: 2128 ident: bib74 article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 378 start-page: 1316 year: 2011 end-page: 1323 ident: bib151 article-title: Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study publication-title: Lancet – volume: 20 start-page: 1993 year: 2006 end-page: 2004 ident: bib116 article-title: Interactions between HIV and malaria in non-pregnant adults: evidence and implications publication-title: AIDS – volume: 17 start-page: 1186 year: 2013 end-page: 1194 ident: bib137 article-title: Assessment of tuberculosis burden in China using a dynamic disease simulation model publication-title: Int J Tuberc Lung Dis – volume: 10 start-page: 545 year: 2010 end-page: 555 ident: bib141 article-title: Changes in the burden of malaria in sub-Saharan Africa publication-title: Lancet Infect Dis – year: 2005 ident: bib9 publication-title: Trends in International Funding for Malaria Control – ident: bib162 article-title: World Malaria Report 2008 – year: 2012 ident: bib32 article-title: South Africa's HIV/Aids battle plan. SouthAfrica.info – volume: 344 start-page: 824 year: 2001 end-page: 831 ident: bib126 article-title: The cost effectiveness of combination antiretroviral therapy for HIV disease publication-title: N Engl J Med – year: 2005 ident: bib73 publication-title: WHO. Guidelines for measuring national HIV prevalence in population-based surveys – volume: 143 start-page: 501 year: 1991 end-page: 504 ident: bib88 article-title: A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire publication-title: Am Rev Respir Dis – volume: 364 start-page: 1428 year: 2004 end-page: 1434 ident: bib124 article-title: Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda publication-title: Lancet – volume: 5 start-page: e80 year: 2008 ident: bib56 article-title: Estimating incidence from prevalence in generalised HIV epidemics: methods and validation publication-title: PLoS Med – volume: 8 start-page: 9 year: 2010 ident: bib85 article-title: Algorithms for enhancing public health utility of national causes-of-death data publication-title: Popul Health Metr – reference: (accessed March 5, 2014). – volume: 376 start-page: 991 year: 2010 end-page: 1023 ident: bib10 article-title: The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre Commission publication-title: Lancet – reference: Ki-moon B. Secretary-General's message on World Malaria Day. – volume: 22 start-page: 2291 year: 2008 end-page: 2302 ident: bib58 article-title: Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies publication-title: AIDS – volume: 376 start-page: 1409 year: 2010 end-page: 1416 ident: bib7 article-title: Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments publication-title: Lancet – volume: 380 start-page: 2224 year: 2012 end-page: 2260 ident: bib48 article-title: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 359 start-page: 2059 year: 2002 end-page: 2064 ident: bib93 article-title: Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study publication-title: Lancet – year: 2013 ident: bib33 article-title: Roadmap for Childhood Tuberculosis – volume: 18 start-page: 562 year: 2014 end-page: 572 ident: bib65 article-title: Female Sex Workers in Three Cities in Russia: HIV Prevalence, Risk Factors and Experience with Targeted HIV Prevention publication-title: AIDS Behav – volume: 131 start-page: 844 year: 2009 end-page: 848 ident: bib18 article-title: The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives publication-title: Am J Clin Pathol – year: 2004 ident: bib36 publication-title: The Millennium Development Goals for Health: Rising to the Challenges – volume: 375 start-page: 1014 year: 2010 end-page: 1028 ident: bib70 article-title: HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage publication-title: Lancet – volume: 36 start-page: 969 year: 2007 end-page: 976 ident: bib57 article-title: Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme publication-title: Int J Epidemiol – volume: 11 start-page: 541 year: 2011 end-page: 556 ident: bib117 article-title: Consequences of HIV infection on malaria and therapeutic implications: a systematic review publication-title: Lancet Infect Dis – volume: 46 start-page: 181 year: 1972 end-page: 202 ident: bib154 article-title: Changes in the pattern of mortality following the eradication of hyperendemic malaria from a highly susceptible community publication-title: Bull World Health Organ – volume: 380 start-page: 2129 year: 2012 end-page: 2143 ident: bib44 article-title: Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 80 start-page: i5 year: 2004 end-page: i9 ident: bib52 article-title: The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics publication-title: Sex Transm Infect – volume: 201 start-page: 618 year: 2010 end-page: 626 ident: bib113 article-title: Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS publication-title: J Infect Dis – volume: 87 start-page: 683 year: 2009 end-page: 691 ident: bib81 article-title: Trends in tuberculosis incidence and their determinants in 134 countries publication-title: Bull World Health Organ – reference: The GBD 2013 Collaboration. Global, Regional, and National Prevalence and Disability for 318 Disease and Injuries and Their 2,435 Sequelae, 1990-2013: A Systematic Analysis. In preparation. – volume: 8 start-page: 564 year: 2008 end-page: 570 ident: bib152 article-title: Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era publication-title: Lancet Infect Dis – year: 2013 ident: bib82 article-title: Global tuberculosis report 2013 – volume: 10 start-page: 1 year: 2012 ident: bib76 article-title: Modeling causes of death: an integrated approach using CODEm publication-title: Popul Health Metr – volume: 7 start-page: e1000241 year: 2010 ident: bib17 article-title: Drivers of inequality in Millennium Development Goal progress: a statistical analysis publication-title: PLoS Med – volume: 380 start-page: 560 year: 2012 end-page: 561 ident: bib97 article-title: New global estimates of malaria deaths publication-title: Lancet – volume: 359 start-page: 1635 year: 2002 end-page: 1643 ident: bib3 article-title: Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence publication-title: Lancet – volume: 7 start-page: e2324 year: 2013 ident: bib146 article-title: Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study publication-title: PLoS Negl Trop Dis – year: 2011 ident: bib83 publication-title: Tuberculosis prevalence surveys: a handbook – reference: Snow RW, Newton CRJC. The public health burden of – volume: 8 start-page: e72616 year: 2013 ident: bib63 article-title: Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men publication-title: PLoS ONE – volume: 347 start-page: 1573 year: 1996 end-page: 1579 ident: bib157 article-title: Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation publication-title: Lancet – volume: 7 start-page: e1000290 year: 2010 ident: bib163 article-title: Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007 publication-title: PLoS Med – year: 2004 ident: bib61 publication-title: Case Study on Estimating HIV Infection in a Concentrated Epidemic: Lessons from Indonesia – volume: 380 start-page: 559 year: 2012 ident: bib96 article-title: New global estimates of malaria deaths publication-title: Lancet – reference: . 2011. – volume: 377 start-page: 1438 year: 2011 end-page: 1447 ident: bib25 article-title: Priority actions for the non-communicable disease crisis publication-title: Lancet – volume: 12 start-page: 5 year: 2014 ident: bib107 article-title: Using verbal autopsy to measure causes of death: the comparative performance of existing methods publication-title: BMC Med – volume: 21 start-page: S1 year: 2007 end-page: S4 ident: bib55 article-title: Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network publication-title: AIDS – volume: 370 start-page: 1929 year: 2007 end-page: 1938 ident: bib26 article-title: The burden and costs of chronic diseases in low-income and middle-income countries publication-title: Lancet – volume: 8 start-page: 1109 year: 2013 end-page: 1122 ident: bib16 article-title: Limitations of the Millennium Development Goals: a literature review publication-title: Glob Public Health – volume: 19 start-page: 309 year: 2005 end-page: 318 ident: bib123 article-title: Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission publication-title: AIDS – reference: WHO Global Task Force on TB Impact Measurement. National TB prevalence surveys. 2014. – volume: 96 start-page: 355 year: 2003 end-page: 362 ident: bib149 article-title: Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description publication-title: QJM – volume: 380 start-page: 560 year: 2012 ident: bib99 article-title: New global estimates of malaria deaths publication-title: Lancet – volume: 329 start-page: 1212 year: 2004 ident: bib147 article-title: Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study publication-title: BMJ – volume: 55 start-page: S65 year: 2013 end-page: S78 ident: bib66 article-title: Systematic review of HIV prevalence studies among key populations in Latin America and the Caribbean publication-title: Salud Publica Mex – ident: bib78 article-title: Demographic Health Surveys Program – year: 2012 ident: bib143 article-title: Q & A on malaria mortality estimates – volume: 82 start-page: iii34 year: 2006 end-page: iii40 ident: bib53 article-title: Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005 publication-title: Sex Transm Infect – ident: bib23 – year: 2012 ident: bib30 article-title: The Zero Declaration – volume: 21 start-page: 509 year: 2007 end-page: 516 ident: bib122 article-title: Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1 publication-title: AIDS – volume: 311 start-page: 183 year: 2014 end-page: 192 ident: bib77 article-title: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012 publication-title: JAMA – volume: 1 start-page: e105 year: 2013 end-page: e115 ident: bib2 article-title: Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002–11, and requirements to meet 2015 targets publication-title: Lancet Glob Health – volume: 21 start-page: S55 year: 2007 end-page: S63 ident: bib54 article-title: Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy publication-title: AIDS – volume: 380 start-page: 2063 year: 2012 end-page: 2066 ident: bib42 article-title: GBD 2010: design, definitions, and metrics publication-title: Lancet – volume: 26 start-page: 765 year: 2012 end-page: 768 ident: bib114 article-title: Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children publication-title: AIDS – volume: 340 start-page: 351 year: 1992 end-page: 355 ident: bib101 article-title: Childhood deaths in Africa: uses and limitations of verbal autopsies publication-title: Lancet – volume: 89 start-page: iii37 year: 2013 end-page: iii40 ident: bib69 article-title: HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010 publication-title: Sex Transm Infect – volume: 23 start-page: 1397 year: 2009 end-page: 1404 ident: bib121 article-title: Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis publication-title: AIDS – year: 2007 ident: bib119 article-title: 2007 AIDS Epidemic Update – ident: bib37 article-title: AIDSinfo Database. Joint United Nations Programme on HIV/AIDS, 2013 – volume: 11 start-page: 681 year: 2006 end-page: 696 ident: bib105 article-title: Validity of verbal autopsy procedures for determining cause of death in Tanzania publication-title: Trop Med Int Health – volume: 8 start-page: 14 year: 2009 ident: bib139 article-title: Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment publication-title: Malar J – year: 2013 ident: bib110 article-title: World Malaria Report. 2013 – ident: bib79 article-title: National Family Health Survey, India. Mumbai, India – volume: 355 start-page: 1141 year: 2006 end-page: 1153 ident: bib127 article-title: Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire publication-title: N Engl J Med – year: 2012 ident: bib34 publication-title: Partnership. No More Crying, No More Dying. Towards Zero TB Deaths In Children – volume: 71 start-page: 16 year: 2004 end-page: 24 ident: bib150 article-title: Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk? publication-title: Am J Trop Med Hyg – year: 2014 ident: bib118 article-title: Incidence of Malaria in HIV-infected and uninfected and Rwandan women from 2005 to 2011 – reference: malaria in Africa: deriving the numbers. Washington DC: The Disease Control Priorities Project (DCPP) Working Paper Number 11, 2003: 75. – volume: 375 start-page: 2092 year: 2010 end-page: 2098 ident: bib120 article-title: Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis publication-title: Lancet – volume: 380 start-page: 2144 year: 2012 end-page: 2162 ident: bib45 article-title: Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010 publication-title: Lancet – volume: 8 start-page: e63476 year: 2013 ident: bib72 article-title: HIV due to female sex work: regional and global estimates publication-title: PLoS ONE – volume: 106 start-page: 688 year: 2012 end-page: 695 ident: bib148 article-title: Severe febrile illness in adult hospital admissions in Tanzania: a prospective study in an area of high malaria transmission publication-title: Trans R Soc Trop Med Hyg – ident: bib160 article-title: AIM: a computer program for making HIV/AIDS projections and examining the demographic and social impacts of AIDS – volume: 127 start-page: 707 year: 2014 end-page: 711 ident: bib68 article-title: HIV and syphilis infections among street-based female sex workers in China, 2010-2012 publication-title: Chin Med J (Engl) – volume: 1 start-page: e62 year: 2013 end-page: e63 ident: bib4 article-title: Financing tuberculosis control: promising trends and remaining challenges publication-title: Lancet Glob Health – ident: bib22 article-title: The Global Economic Burden of Non-communicable Diseases. Glob. Econ. Burd. Non-Commun. Dis. World Econ. Forum – ident: bib24 article-title: Tackling Non-communicable Diseases to Enhance Sustainable Development. NCD Alliance, 2014 – volume: 379 start-page: 413 year: 2012 end-page: 431 ident: bib94 article-title: Global malaria mortality between 1980 and 2010: a systematic analysis publication-title: Lancet – volume: 330 start-page: 1551 year: 2010 end-page: 1557 ident: bib112 article-title: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation publication-title: Science – volume: 345 start-page: 479 year: 1995 end-page: 483 ident: bib155 article-title: Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme publication-title: Lancet – ident: bib136 article-title: Global tuberculosis control 2010 – volume: 9 start-page: 415 year: 1995 end-page: 421 ident: bib90 article-title: Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988-1993 publication-title: J Acquir Immune Defic Syndr Hum Retrovirol – volume: 89 start-page: 278 year: 2011 end-page: 285 ident: bib75 article-title: Exposing misclassified HIV/AIDS deaths in South Africa publication-title: Bull World Health Organ – volume: 380 start-page: 559 year: 2012 end-page: 560 ident: bib100 article-title: New global estimates of malaria deaths publication-title: Lancet – reference: Roll Back Malaria. Malaria Funding & Resource Utilization: The First Decade of Roll Back Malaria. 2010. – volume: 16 start-page: 18751 year: 2013 ident: bib62 article-title: Epidemiology of HIV among female sex workers, their clients, men who have sex with men and people who inject drugs in West and Central Africa publication-title: J Int AIDS Soc – volume: 25 start-page: 53 year: 2014 end-page: 60 ident: bib129 article-title: What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries publication-title: Int J Drug Policy – volume: 68 start-page: 2240 year: 2009 end-page: 2246 ident: bib132 article-title: Drivers of tuberculosis epidemics: the role of risk factors and social determinants publication-title: Soc Sci Med – volume: 381 start-page: 566 year: 2013 end-page: 574 ident: bib19 article-title: Embedding non-communicable diseases in the post-2015 development agenda publication-title: Lancet – volume: 7 start-page: e49526 year: 2012 ident: bib111 article-title: High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression publication-title: PLoS ONE – volume: 29 start-page: 1547 year: 2013 end-page: 1552 ident: bib67 article-title: A cross-sectional analysis of population demographics, HIV knowledge and risk behaviors, and prevalence and associations of HIV among men who have sex with men in the Gambia publication-title: AIDS Res Hum Retroviruses – volume: 26 start-page: 2233 year: 2012 end-page: 2239 ident: bib91 article-title: The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting publication-title: AIDS – volume: 5 start-page: e12242 year: 2010 ident: bib159 article-title: Continued decline of malaria in The Gambia with implications for elimination publication-title: PLoS ONE – volume: 5 start-page: e142 year: 2008 ident: bib6 article-title: International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission publication-title: PLoS Med – ident: bib39 article-title: Methodology - Understanding the HIV estimates. Geneva, Switzerland, 2013 – volume: 366 start-page: 2161 year: 2012 end-page: 2170 ident: bib135 article-title: National survey of drug-resistant tuberculosis in China publication-title: N Engl J Med – volume: 167 start-page: 335 year: 2007 end-page: 342 ident: bib131 article-title: Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis publication-title: Arch Intern Med – volume: 191 start-page: 150 year: 2005 end-page: 158 ident: bib86 article-title: How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners publication-title: J Infect Dis – volume: 10 start-page: e1001477 year: 2013 ident: bib95 article-title: Reflections on the global burden of disease 2010 estimates publication-title: PLoS Med – volume: 207 start-page: 72 year: 2013 end-page: 79 ident: bib59 article-title: Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs publication-title: J Infect Dis – volume: 337 start-page: 1499 year: 1991 end-page: 1502 ident: bib156 article-title: The effect of insecticide-treated bed nets on mortality of Gambian children publication-title: Lancet – volume: 380 start-page: 2163 year: 2012 end-page: 2196 ident: bib46 article-title: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 13 start-page: 177 year: 1996 end-page: 183 ident: bib92 article-title: Tuberculosis and HIV infection among female inmates in São Paulo, Brazil: a prospective cohort study publication-title: J Acquir Immune Defic Syndr Hum Retrovirol – volume: 376 start-page: 1254 year: 2010 end-page: 1260 ident: bib5 article-title: Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31 publication-title: Lancet – volume: 4 start-page: 20 year: 2006 ident: bib128 article-title: The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa-a primary data analysis publication-title: Cost Eff Resour Alloc – volume: 377 start-page: 991 year: 2011 ident: bib145 article-title: Malaria-attributed death rates in India publication-title: Lancet – volume: 41 start-page: 60 year: 2010 end-page: 69 ident: bib28 article-title: Taking the MDGs Beyond 2015: Hasten Slowly publication-title: IDS Bull – year: 2014 ident: bib142 article-title: The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity publication-title: Lancet – volume: 10 start-page: 378 year: 2011 ident: bib108 article-title: A new world malaria map: Plasmodium falciparum endemicity in 2010 publication-title: Malar J – reference: The GBD 2013 Collaboration. Global, Regional, and National Levels of Age-Specific Mortality and 266 Causes of Death, 1990–2013: A Systematic Analysis. In preparation. – volume: 14 start-page: 31 year: 1994 end-page: 36 ident: bib104 article-title: The limitations of verbal autopsy in a malaria-endemic region publication-title: Ann Trop Paediatr – reference: The GBD 2013 Collaboration. Global, Regional, and National Burden of Disease for 322 Disease and Injuries and 68 Risk Factors, 1990-2013: A Systematic Analysis. In preparation. – volume: 35 start-page: 249 year: 2012 end-page: 257 ident: bib115 article-title: Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression publication-title: New Microbiol – volume: 83 start-page: 44 year: 2003 end-page: 51 ident: bib133 article-title: The global situation of MDR-TB publication-title: Tuberculosis (Edinb) – volume: 146 start-page: 1439 year: 1992 end-page: 1444 ident: bib87 article-title: Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women publication-title: Am Rev Respir Dis – volume: 88 start-page: i11 year: 2012 end-page: i16 ident: bib38 article-title: Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children publication-title: Sex Transm Infect – volume: 35 start-page: 735 year: 2007 end-page: 751 ident: bib13 article-title: The Trouble with the MDGs: Confronting Expectations of Aid and Development Success publication-title: World Dev – volume: 380 start-page: 2055 year: 2012 end-page: 2058 ident: bib41 article-title: GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology publication-title: Lancet – year: 2013 ident: bib12 publication-title: The Millennium Development Goals Report 2013 – volume: 9 start-page: 299 year: 2010 ident: bib140 article-title: Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects publication-title: Malar J – volume: 15 start-page: 3 year: 2013 ident: bib20 article-title: NCDs: can healthy synergies replace fatal interactions? publication-title: MEDICC Rev – volume: 44 start-page: 842 year: 2013 end-page: 853 ident: bib64 article-title: Gender and ethnic disparities of HIV and syphilis seroconversions in a 4-year cohort of injection drug users publication-title: Southeast Asian J Trop Med Public Health – volume: 372 start-page: 1733 year: 2008 end-page: 1745 ident: bib71 article-title: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review publication-title: Lancet – volume: 23 start-page: 95 year: 2008 end-page: 100 ident: bib27 article-title: Has donor prioritization of HIV/AIDS displaced aid for other health issues? publication-title: Health Policy Plan – volume: 6 start-page: e26892 year: 2011 ident: bib102 article-title: Validity of verbal autopsy procedures for determining malaria deaths in different epidemiological settings in Uganda publication-title: PLoS ONE – volume: 380 start-page: 2071 year: 2012 end-page: 2094 ident: bib43 article-title: Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet – volume: 46 start-page: 181 year: 1972 ident: 10.1016/S0140-6736(14)60844-8_bib154 article-title: Changes in the pattern of mortality following the eradication of hyperendemic malaria from a highly susceptible community publication-title: Bull World Health Organ – volume: 12 start-page: 18 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib8 article-title: Progress towards malaria control targets in relation to national malaria programme funding publication-title: Malar J doi: 10.1186/1475-2875-12-18 – volume: 8 start-page: 1109 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib16 article-title: Limitations of the Millennium Development Goals: a literature review publication-title: Glob Public Health doi: 10.1080/17441692.2013.845676 – volume: 340 start-page: 351 year: 1992 ident: 10.1016/S0140-6736(14)60844-8_bib101 article-title: Childhood deaths in Africa: uses and limitations of verbal autopsies publication-title: Lancet doi: 10.1016/0140-6736(92)91414-4 – volume: 11 start-page: 681 year: 2006 ident: 10.1016/S0140-6736(14)60844-8_bib105 article-title: Validity of verbal autopsy procedures for determining cause of death in Tanzania publication-title: Trop Med Int Health doi: 10.1111/j.1365-3156.2006.01603.x – volume: 311 start-page: 183 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib77 article-title: Smoking prevalence and cigarette consumption in 187 countries, 1980-2012 publication-title: JAMA doi: 10.1001/jama.2013.284692 – volume: 377 start-page: 991 year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib145 article-title: Malaria-attributed death rates in India publication-title: Lancet doi: 10.1016/S0140-6736(11)60378-4 – volume: 21 start-page: 509 year: 2007 ident: 10.1016/S0140-6736(14)60844-8_bib122 article-title: Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1 publication-title: AIDS doi: 10.1097/QAD.0b013e32801424d2 – volume: 89 start-page: 278 year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib75 article-title: Exposing misclassified HIV/AIDS deaths in South Africa publication-title: Bull World Health Organ doi: 10.2471/BLT.11.086280 – volume: 201 start-page: 618 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib113 article-title: Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS publication-title: J Infect Dis doi: 10.1086/649842 – volume: 167 start-page: 335 year: 2007 ident: 10.1016/S0140-6736(14)60844-8_bib131 article-title: Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis publication-title: Arch Intern Med doi: 10.1001/archinte.167.4.335 – volume: 10 start-page: 545 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib141 article-title: Changes in the burden of malaria in sub-Saharan Africa publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(10)70096-7 – volume: 41 start-page: 60 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib28 article-title: Taking the MDGs Beyond 2015: Hasten Slowly publication-title: IDS Bull doi: 10.1111/j.1759-5436.2010.00105.x – volume: 359 start-page: 1635 year: 2002 ident: 10.1016/S0140-6736(14)60844-8_bib3 article-title: Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence publication-title: Lancet doi: 10.1016/S0140-6736(02)08595-1 – volume: 376 start-page: 1409 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib7 article-title: Equity and adequacy of international donor assistance for global malaria control: an analysis of populations at risk and external funding commitments publication-title: Lancet doi: 10.1016/S0140-6736(10)61340-2 – volume: 18 start-page: 562 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib65 article-title: Female Sex Workers in Three Cities in Russia: HIV Prevalence, Risk Factors and Experience with Targeted HIV Prevention publication-title: AIDS Behav doi: 10.1007/s10461-013-0577-y – volume: 14 start-page: 31 year: 1994 ident: 10.1016/S0140-6736(14)60844-8_bib104 article-title: The limitations of verbal autopsy in a malaria-endemic region publication-title: Ann Trop Paediatr doi: 10.1080/02724936.1994.11747689 – volume: 8 start-page: e72616 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib63 article-title: Is the HIV epidemic stable among MSM in Mexico? HIV prevalence and risk behavior results from a nationally representative survey among men who have sex with men publication-title: PLoS ONE doi: 10.1371/journal.pone.0072616 – ident: 10.1016/S0140-6736(14)60844-8_bib84 – volume: 380 start-page: 559 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib96 article-title: New global estimates of malaria deaths publication-title: Lancet doi: 10.1016/S0140-6736(12)61320-8 – ident: 10.1016/S0140-6736(14)60844-8_bib35 – volume: 83 start-page: 44 year: 2003 ident: 10.1016/S0140-6736(14)60844-8_bib133 article-title: The global situation of MDR-TB publication-title: Tuberculosis (Edinb) doi: 10.1016/S1472-9792(02)00058-6 – volume: 21 start-page: S1 issue: suppl 6 year: 2007 ident: 10.1016/S0140-6736(14)60844-8_bib55 article-title: Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network publication-title: AIDS doi: 10.1097/01.aids.0000299404.99033.bf – volume: 19 start-page: 309 year: 2005 ident: 10.1016/S0140-6736(14)60844-8_bib123 article-title: Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission publication-title: AIDS – volume: 380 start-page: 559 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib100 article-title: New global estimates of malaria deaths publication-title: Lancet doi: 10.1016/S0140-6736(12)61321-X – volume: 80 start-page: i5 issue: suppl 1 year: 2004 ident: 10.1016/S0140-6736(14)60844-8_bib52 article-title: The UNAIDS Estimation and Projection Package: a software package to estimate and project national HIV epidemics publication-title: Sex Transm Infect doi: 10.1136/sti.2004.010199 – volume: 377 start-page: 1438 year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib25 article-title: Priority actions for the non-communicable disease crisis publication-title: Lancet doi: 10.1016/S0140-6736(11)60393-0 – volume: 35 start-page: 735 year: 2007 ident: 10.1016/S0140-6736(14)60844-8_bib13 article-title: The Trouble with the MDGs: Confronting Expectations of Aid and Development Success publication-title: World Dev doi: 10.1016/j.worlddev.2006.08.003 – volume: 364 start-page: 1865 year: 2004 ident: 10.1016/S0140-6736(14)60844-8_bib125 article-title: Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(04)17442-4 – volume: 337 start-page: 1499 year: 1991 ident: 10.1016/S0140-6736(14)60844-8_bib156 article-title: The effect of insecticide-treated bed nets on mortality of Gambian children publication-title: Lancet doi: 10.1016/0140-6736(91)93194-E – volume: 23 start-page: 95 year: 2008 ident: 10.1016/S0140-6736(14)60844-8_bib27 article-title: Has donor prioritization of HIV/AIDS displaced aid for other health issues? publication-title: Health Policy Plan doi: 10.1093/heapol/czm045 – volume: 375 start-page: 2092 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib120 article-title: Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis publication-title: Lancet doi: 10.1016/S0140-6736(10)60705-2 – ident: 10.1016/S0140-6736(14)60844-8_bib49 – volume: 10 start-page: 378 year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib108 article-title: A new world malaria map: Plasmodium falciparum endemicity in 2010 publication-title: Malar J doi: 10.1186/1475-2875-10-378 – volume: 376 start-page: 940 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib14 article-title: Tuberculosis control is crucial to achieve the MDGs publication-title: Lancet doi: 10.1016/S0140-6736(10)61428-6 – volume: 71 start-page: 16 issue: suppl year: 2004 ident: 10.1016/S0140-6736(14)60844-8_bib150 article-title: Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk? publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2004.71.16 – year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib34 – volume: 15 start-page: 3 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib20 article-title: NCDs: can healthy synergies replace fatal interactions? publication-title: MEDICC Rev – volume: 96 start-page: 355 year: 2003 ident: 10.1016/S0140-6736(14)60844-8_bib149 article-title: Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description publication-title: QJM doi: 10.1093/qjmed/hcg059 – volume: 381 start-page: 566 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib19 article-title: Embedding non-communicable diseases in the post-2015 development agenda publication-title: Lancet doi: 10.1016/S0140-6736(12)61806-6 – volume: 5 start-page: e142 year: 2008 ident: 10.1016/S0140-6736(14)60844-8_bib6 article-title: International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission publication-title: PLoS Med doi: 10.1371/journal.pmed.0050142 – volume: 17 start-page: 1186 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib137 article-title: Assessment of tuberculosis burden in China using a dynamic disease simulation model publication-title: Int J Tuberc Lung Dis doi: 10.5588/ijtld.12.0959 – volume: 143 start-page: 501 year: 1991 ident: 10.1016/S0140-6736(14)60844-8_bib88 article-title: A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/143.3.501 – volume: 20 start-page: 1993 year: 2006 ident: 10.1016/S0140-6736(14)60844-8_bib116 article-title: Interactions between HIV and malaria in non-pregnant adults: evidence and implications publication-title: AIDS doi: 10.1097/01.aids.0000247572.95880.92 – volume: 7 start-page: e1000290 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib163 article-title: Estimating the Global Clinical Burden of Plasmodium falciparum Malaria in 2007 publication-title: PLoS Med doi: 10.1371/journal.pmed.1000290 – volume: 9 start-page: 415 year: 1995 ident: 10.1016/S0140-6736(14)60844-8_bib90 article-title: Four years of natural history of HIV-1 infection in african women: a prospective cohort study in Kigali (Rwanda), 1988-1993 publication-title: J Acquir Immune Defic Syndr Hum Retrovirol doi: 10.1097/00042560-199508000-00013 – volume: 207 start-page: 72 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib59 article-title: Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs publication-title: J Infect Dis doi: 10.1093/infdis/jis635 – volume: 364 start-page: 1428 year: 2004 ident: 10.1016/S0140-6736(14)60844-8_bib124 article-title: Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda publication-title: Lancet doi: 10.1016/S0140-6736(04)17225-5 – volume: 34 start-page: 271 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib11 article-title: Prospects for tuberculosis elimination publication-title: Annu Rev Public Health doi: 10.1146/annurev-publhealth-031912-114431 – volume: 89 start-page: iii37 issue: suppl 3 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib69 article-title: HIV prevalence and related risk behaviours among female sex workers in Iran: results of the national biobehavioural survey, 2010 publication-title: Sex Transm Infect doi: 10.1136/sextrans-2013-051028 – volume: 347 start-page: 1573 year: 1996 ident: 10.1016/S0140-6736(14)60844-8_bib157 article-title: Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation publication-title: Lancet doi: 10.1016/S0140-6736(96)91073-9 – volume: 72 start-page: 731 year: 1995 ident: 10.1016/S0140-6736(14)60844-8_bib103 article-title: Verbal autopsy as a technique to establish causes of infant and child mortality publication-title: East Afr Med J – volume: 1 start-page: e105 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib2 article-title: Domestic and donor financing for tuberculosis care and control in low-income and middle-income countries: an analysis of trends, 2002–11, and requirements to meet 2015 targets publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(13)70032-9 – volume: 380 start-page: 2144 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib45 article-title: Healthy life expectancy for 187 countries, 1990–2010: a systematic analysis for the Global Burden Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61690-0 – volume: 7 start-page: e1000241 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib17 article-title: Drivers of inequality in Millennium Development Goal progress: a statistical analysis publication-title: PLoS Med doi: 10.1371/journal.pmed.1000241 – volume: 359 start-page: 2059 year: 2002 ident: 10.1016/S0140-6736(14)60844-8_bib93 article-title: Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study publication-title: Lancet doi: 10.1016/S0140-6736(02)08904-3 – volume: 380 start-page: 2129 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib44 article-title: Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61680-8 – volume: 29 start-page: 1547 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib67 article-title: A cross-sectional analysis of population demographics, HIV knowledge and risk behaviors, and prevalence and associations of HIV among men who have sex with men in the Gambia publication-title: AIDS Res Hum Retroviruses doi: 10.1089/aid.2013.0092 – ident: 10.1016/S0140-6736(14)60844-8_bib80 – volume: 191 start-page: 150 year: 2005 ident: 10.1016/S0140-6736(14)60844-8_bib86 article-title: How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners publication-title: J Infect Dis doi: 10.1086/426827 – volume: 44 start-page: 842 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib64 article-title: Gender and ethnic disparities of HIV and syphilis seroconversions in a 4-year cohort of injection drug users publication-title: Southeast Asian J Trop Med Public Health – volume: 88 start-page: i11 issue: suppl 2 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib38 article-title: Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children publication-title: Sex Transm Infect doi: 10.1136/sextrans-2012-050640 – volume: 35 start-page: 249 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib115 article-title: Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression publication-title: New Microbiol – volume: 370 start-page: 1929 year: 2007 ident: 10.1016/S0140-6736(14)60844-8_bib26 article-title: The burden and costs of chronic diseases in low-income and middle-income countries publication-title: Lancet doi: 10.1016/S0140-6736(07)61696-1 – volume: 8 start-page: e63476 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib72 article-title: HIV due to female sex work: regional and global estimates publication-title: PLoS ONE doi: 10.1371/journal.pone.0063476 – volume: 10 start-page: e1001477 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib95 article-title: Reflections on the global burden of disease 2010 estimates publication-title: PLoS Med doi: 10.1371/journal.pmed.1001477 – volume: 380 start-page: 2197 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib47 article-title: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61689-4 – ident: 10.1016/S0140-6736(14)60844-8_bib50 – volume: 55 start-page: S65 issue: suppl 1 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib66 article-title: Systematic review of HIV prevalence studies among key populations in Latin America and the Caribbean publication-title: Salud Publica Mex doi: 10.21149/spm.v55s1.5099 – volume: 127 start-page: 707 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib68 article-title: HIV and syphilis infections among street-based female sex workers in China, 2010-2012 publication-title: Chin Med J (Engl) doi: 10.3760/cma.j.issn.0366-6999.20131502 – volume: 87 start-page: 683 year: 2009 ident: 10.1016/S0140-6736(14)60844-8_bib81 article-title: Trends in tuberculosis incidence and their determinants in 134 countries publication-title: Bull World Health Organ doi: 10.2471/BLT.08.058453 – ident: 10.1016/S0140-6736(14)60844-8_bib24 – volume: 106 start-page: 688 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib148 article-title: Severe febrile illness in adult hospital admissions in Tanzania: a prospective study in an area of high malaria transmission publication-title: Trans R Soc Trop Med Hyg doi: 10.1016/j.trstmh.2012.08.006 – volume: 375 start-page: 1014 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib70 article-title: HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage publication-title: Lancet doi: 10.1016/S0140-6736(10)60232-2 – volume: 330 start-page: 1551 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib112 article-title: The major genetic determinants of HIV-1 control affect HLA class I peptide presentation publication-title: Science doi: 10.1126/science.1195271 – ident: 10.1016/S0140-6736(14)60844-8_bib51 – volume: 380 start-page: 560 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib99 article-title: New global estimates of malaria deaths publication-title: Lancet doi: 10.1016/S0140-6736(12)61322-1 – volume: 146 start-page: 1439 year: 1992 ident: 10.1016/S0140-6736(14)60844-8_bib87 article-title: Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/146.6.1439 – volume: 355 start-page: 1141 year: 2006 ident: 10.1016/S0140-6736(14)60844-8_bib127 article-title: Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire publication-title: N Engl J Med doi: 10.1056/NEJMsa060247 – year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib12 – year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib142 article-title: The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity publication-title: Lancet doi: 10.1016/S0140-6736(13)62566-0 – volume: 23 start-page: 1397 year: 2009 ident: 10.1016/S0140-6736(14)60844-8_bib121 article-title: Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis publication-title: AIDS doi: 10.1097/QAD.0b013e32832b7dca – volume: 7 start-page: e49526 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib111 article-title: High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression publication-title: PLoS ONE doi: 10.1371/journal.pone.0049526 – volume: 380 start-page: 2071 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib43 article-title: Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61719-X – volume: 3 start-page: 436 year: 1998 ident: 10.1016/S0140-6736(14)60844-8_bib106 article-title: Verbal autopsies for adult deaths: their development and validation in a multicentre study publication-title: Trop Med Int Health doi: 10.1046/j.1365-3156.1998.00255.x – volume: 8 start-page: 9 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib85 article-title: Algorithms for enhancing public health utility of national causes-of-death data publication-title: Popul Health Metr doi: 10.1186/1478-7954-8-9 – ident: 10.1016/S0140-6736(14)60844-8_bib1 – volume: 366 start-page: 2161 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib135 article-title: National survey of drug-resistant tuberculosis in China publication-title: N Engl J Med doi: 10.1056/NEJMoa1108789 – volume: 9 start-page: 299 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib140 article-title: Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects publication-title: Malar J doi: 10.1186/1475-2875-9-299 – volume: 28 start-page: 205 year: 1974 ident: 10.1016/S0140-6736(14)60844-8_bib153 article-title: The decline of mortality in Ceylon and the demographic effects of malaria control publication-title: Popul Stud (Camb) doi: 10.1080/00324728.1974.10405176 – volume: 344 start-page: 824 year: 2001 ident: 10.1016/S0140-6736(14)60844-8_bib126 article-title: The cost effectiveness of combination antiretroviral therapy for HIV disease publication-title: N Engl J Med doi: 10.1056/NEJM200103153441108 – volume: 68 start-page: 2240 year: 2009 ident: 10.1016/S0140-6736(14)60844-8_bib132 article-title: Drivers of tuberculosis epidemics: the role of risk factors and social determinants publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2009.03.041 – volume: 7 start-page: e2324 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib146 article-title: Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0002324 – volume: 378 start-page: 1316 year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib151 article-title: Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study publication-title: Lancet doi: 10.1016/S0140-6736(11)60888-X – volume: 379 start-page: 413 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib94 article-title: Global malaria mortality between 1980 and 2010: a systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(12)60034-8 – volume: 135 start-page: 270 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib144 article-title: Defining & counting malaria deaths publication-title: Indian J Med Res – volume: 380 start-page: 560 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib97 article-title: New global estimates of malaria deaths publication-title: Lancet doi: 10.1016/S0140-6736(12)61323-3 – volume: 194 start-page: 479 year: 2006 ident: 10.1016/S0140-6736(14)60844-8_bib134 article-title: Global incidence of multidrug-resistant tuberculosis publication-title: J Infect Dis doi: 10.1086/505877 – volume: 8 start-page: 14 year: 2009 ident: 10.1016/S0140-6736(14)60844-8_bib139 article-title: Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment publication-title: Malar J doi: 10.1186/1475-2875-8-14 – volume: 5 start-page: e12242 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib159 article-title: Continued decline of malaria in The Gambia with implications for elimination publication-title: PLoS ONE doi: 10.1371/journal.pone.0012242 – volume: 21 start-page: S55 issue: suppl 6 year: 2007 ident: 10.1016/S0140-6736(14)60844-8_bib54 article-title: Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy publication-title: AIDS doi: 10.1097/01.aids.0000299411.75269.e8 – ident: 10.1016/S0140-6736(14)60844-8_bib138 – volume: 11 start-page: 541 year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib117 article-title: Consequences of HIV infection on malaria and therapeutic implications: a systematic review publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(11)70031-7 – volume: 376 start-page: 991 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib10 article-title: The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015 Lancet and London International Development Centre Commission publication-title: Lancet doi: 10.1016/S0140-6736(10)61196-8 – volume: 8 start-page: 564 year: 2008 ident: 10.1016/S0140-6736(14)60844-8_bib152 article-title: Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(08)70130-0 – volume: 26 start-page: 2233 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib91 article-title: The impact of HIV and ART on recurrent tuberculosis in a sub-Saharan setting publication-title: AIDS doi: 10.1097/QAD.0b013e32835958ed – volume: 13 start-page: 177 year: 1996 ident: 10.1016/S0140-6736(14)60844-8_bib92 article-title: Tuberculosis and HIV infection among female inmates in São Paulo, Brazil: a prospective cohort study publication-title: J Acquir Immune Defic Syndr Hum Retrovirol doi: 10.1097/00042560-199610010-00009 – volume: 26 start-page: 765 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib114 article-title: Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children publication-title: AIDS doi: 10.1097/QAD.0b013e3283514350 – volume: 5 start-page: e80 year: 2008 ident: 10.1016/S0140-6736(14)60844-8_bib56 article-title: Estimating incidence from prevalence in generalised HIV epidemics: methods and validation publication-title: PLoS Med doi: 10.1371/journal.pmed.0050080 – volume: 380 start-page: 2224 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib48 article-title: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61766-8 – volume: 10 start-page: 1 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib76 article-title: Modeling causes of death: an integrated approach using CODEm publication-title: Popul Health Metr doi: 10.1186/1478-7954-10-1 – year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib83 – volume: 25 start-page: 53 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib129 article-title: What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries publication-title: Int J Drug Policy doi: 10.1016/j.drugpo.2013.08.004 – volume: 345 start-page: 479 year: 1995 ident: 10.1016/S0140-6736(14)60844-8_bib155 article-title: Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme publication-title: Lancet doi: 10.1016/S0140-6736(95)90582-0 – volume: 380 start-page: 2063 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib42 article-title: GBD 2010: design, definitions, and metrics publication-title: Lancet doi: 10.1016/S0140-6736(12)61899-6 – year: 2004 ident: 10.1016/S0140-6736(14)60844-8_bib61 – volume: 7 start-page: 23695 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib15 article-title: The Millennium Development Goals: experiences, achievements and what's next publication-title: Glob Health Action doi: 10.3402/gha.v7.23695 – volume: 28 start-page: S25 issue: suppl 1 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib40 article-title: The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models publication-title: AIDS doi: 10.1097/QAD.0000000000000085 – volume: 131 start-page: 844 year: 2009 ident: 10.1016/S0140-6736(14)60844-8_bib18 article-title: The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives publication-title: Am J Clin Pathol doi: 10.1309/AJCP5XHDB1PNAEYT – volume: 379 start-page: 707 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib98 article-title: UN Envoy's response to estimates of global malaria mortality publication-title: Lancet doi: 10.1016/S0140-6736(12)60280-3 – volume: 380 start-page: 2095 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib74 article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61728-0 – volume: 12 start-page: 5 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib107 article-title: Using verbal autopsy to measure causes of death: the comparative performance of existing methods publication-title: BMC Med doi: 10.1186/1741-7015-12-5 – volume: 1 start-page: e62 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib4 article-title: Financing tuberculosis control: promising trends and remaining challenges publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(13)70044-5 – volume: 22 start-page: 2291 year: 2008 ident: 10.1016/S0140-6736(14)60844-8_bib58 article-title: Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies publication-title: AIDS doi: 10.1097/QAD.0b013e3283121ca9 – ident: 10.1016/S0140-6736(14)60844-8_bib164 – volume: 372 start-page: 1545 year: 2008 ident: 10.1016/S0140-6736(14)60844-8_bib158 article-title: Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis publication-title: Lancet doi: 10.1016/S0140-6736(08)61654-2 – volume: 376 start-page: 1254 year: 2010 ident: 10.1016/S0140-6736(14)60844-8_bib5 article-title: Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009-31 publication-title: Lancet doi: 10.1016/S0140-6736(10)61255-X – volume: 4 start-page: 20 year: 2006 ident: 10.1016/S0140-6736(14)60844-8_bib128 article-title: The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa-a primary data analysis publication-title: Cost Eff Resour Alloc doi: 10.1186/1478-7547-4-20 – year: 2004 ident: 10.1016/S0140-6736(14)60844-8_bib36 – volume: 33 start-page: 878 year: 2014 ident: 10.1016/S0140-6736(14)60844-8_bib109 article-title: Global health development assistance remained steady in 2013 but did not align with recipients' disease burden publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.2013.1432 – volume: 36 start-page: 969 year: 2007 ident: 10.1016/S0140-6736(14)60844-8_bib57 article-title: Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme publication-title: Int J Epidemiol doi: 10.1093/ije/dym073 – volume: 16 start-page: 18751 issue: suppl 3 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib62 article-title: Epidemiology of HIV among female sex workers, their clients, men who have sex with men and people who inject drugs in West and Central Africa publication-title: J Int AIDS Soc doi: 10.7448/IAS.16.4.18751 – volume: 2013 start-page: 828939 year: 2013 ident: 10.1016/S0140-6736(14)60844-8_bib130 article-title: Risk factors for tuberculosis publication-title: Pulm Med doi: 10.1155/2013/828939 – volume: 379 start-page: 2151 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib161 article-title: Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 publication-title: Lancet doi: 10.1016/S0140-6736(12)60560-1 – volume: 380 start-page: 2163 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib46 article-title: Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 publication-title: Lancet doi: 10.1016/S0140-6736(12)61729-2 – ident: 10.1016/S0140-6736(14)60844-8_bib118 – volume: 6 start-page: e26892 year: 2011 ident: 10.1016/S0140-6736(14)60844-8_bib102 article-title: Validity of verbal autopsy procedures for determining malaria deaths in different epidemiological settings in Uganda publication-title: PLoS ONE doi: 10.1371/journal.pone.0026892 – volume: 329 start-page: 1212 year: 2004 ident: 10.1016/S0140-6736(14)60844-8_bib147 article-title: Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study publication-title: BMJ doi: 10.1136/bmj.38251.658229.55 – year: 2005 ident: 10.1016/S0140-6736(14)60844-8_bib9 – year: 2005 ident: 10.1016/S0140-6736(14)60844-8_bib73 – volume: 54 start-page: 64 year: 2000 ident: 10.1016/S0140-6736(14)60844-8_bib89 article-title: How does tuberculosis relate to HIV positive and HIV negative drug users? publication-title: J Epidemiol Community Health doi: 10.1136/jech.54.1.64 – volume: 82 start-page: iii34 issue: suppl 3 year: 2006 ident: 10.1016/S0140-6736(14)60844-8_bib53 article-title: Improving projections at the country level: the UNAIDS Estimation and Projection Package 2005 publication-title: Sex Transm Infect – volume: 372 start-page: 1733 year: 2008 ident: 10.1016/S0140-6736(14)60844-8_bib71 article-title: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review publication-title: Lancet doi: 10.1016/S0140-6736(08)61311-2 – volume: 380 start-page: 2055 year: 2012 ident: 10.1016/S0140-6736(14)60844-8_bib41 article-title: GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology publication-title: Lancet doi: 10.1016/S0140-6736(12)62134-5 – reference: 25059946 - Lancet. 2014 Sep 13;384(9947):937-8. doi: 10.1016/S0140-6736(14)61062-X. – reference: 25933281 - Lancet. 2015 Apr 18;385(9977):1510. doi: 10.1016/S0140-6736(15)60753-X. – reference: - Lancet. 2014 Oct 25;384(9953):1504 – reference: 25845784 - Lancet. 2015 Mar 28;385(9974):1177. doi: 10.1016/S0140-6736(15)60626-2. – reference: - Lancet. 2014 Sep 13;384(9947):956 – reference: 25073423 - Lancet. 2014 Sep 13;384(9947):935-6. doi: 10.1016/S0140-6736(14)61222-8. – reference: 36661238 - Br J Haematol. 2023 May;201(4):599-601. doi: 10.1111/bjh.18651. |
| SSID | ssj0004605 |
| Score | 2.6313348 |
| Snippet | The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal... Summary Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium... Background The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium... Background: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium... BACKGROUND: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium... |
| SourceID | wageningen swepub pubmedcentral proquest pubmed pascalfrancis crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1005 |
| SubjectTerms | ACTIVE ANTIRETROVIRAL THERAPY Age Distribution Antiretroviral agents Biological and medical sciences COST-EFFECTIVENESS Developing countries Drug resistance Epidemics Epidemics - statistics & numerical data Epidemiology Fatalities Female FEMALE SEX WORKERS Folkhälsovetenskap, global hälsa och socialmedicin General & Internal General aspects Global Health - trends Health and Welfare Health risk assessment HIV Infections - epidemiology Human immunodeficiency virus Human viral diseases Humans Hälsa och välfärd Incidence Infectious diseases Infectious Medicine Infektionsmedicin Insecticides Internal Medicine LDCs MALARIA Malaria - epidemiology Male Medical research Medical sciences Medicine MIDDLE-INCOME COUNTRIES MILLENNIUM DEVELOPMENT GOALS Mortality Mortality - trends Mycobacterium Organizational Objectives PACKAGE PLASMODIUM-FALCIPARUM plasmodium-falciparum malaria PROJECTION projection package PROSPECTIVE COHORT Public health Public Health, Global Health and Social Medicine Public health. Hygiene Public health. Hygiene-occupational medicine SEVERE FEBRILE ILLNESS Sex Distribution Systematic review Tuberculosis Tuberculosis - epidemiology Vector-borne diseases VERBAL AUTOPSY Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
| Title | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0140673614608448 https://www.clinicalkey.es/playcontent/1-s2.0-S0140673614608448 https://dx.doi.org/10.1016/S0140-6736(14)60844-8 https://www.ncbi.nlm.nih.gov/pubmed/25059949 https://www.proquest.com/docview/1622597602 https://www.proquest.com/docview/1562441285 https://www.proquest.com/docview/1635023000 https://pubmed.ncbi.nlm.nih.gov/PMC4202387 https://urn.kb.se/resolve?urn=urn:nbn:se:du-21324 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-229029 https://gup.ub.gu.se/publication/203989 http://kipublications.ki.se/Default.aspx?queryparsed=id:129737235 http://www.narcis.nl/publication/RecordID/oai:library.wur.nl:wurpubs%2F480400 |
| Volume | 384 |
| WOSCitedRecordID | wos000341679700032&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database (ProQuest) customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Health Management Database customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Public Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250914 omitProxy: false ssIdentifier: ssj0004605 issn: 1474-547X databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1rb9Mw0IINoaGJx3gVRmWkgUBqWOy4jcsXNPbQ-NBSjanqN8t5lYguLU3DxI_iP3JnpykVXYfEl0vj3KVOci8_7o6QPa8Jdi1OPMdLEu2IUDIH-EY4vKVBvjQHHhGm2ITf7crBoN0rJ9zyclvlXCcaRR2NQ5wj32ct4DywnS7_MPnuYNUoXF0tS2jcJJtYNhv53B_4q-IizRb3RQTP_peq8Q0Tb1uuFMKRV9mm7YnO4Y0lttTFKl_07y2VZeLRO2TrEhRDZiKl_rBcJ_f-95nvk7ulz0oPLJM9IDfibIfc7pSr8jtk2879URvS9JD8soUEGhSrPqCn36A6i-h83pHi9L4pZWqaL8wAAAYDFPxnevqp36CzIoinYTEa52luaS80jMBTTW1UJWVg3UDymPeearpIRg2oNsWKuRW4ttT2hNpgDTpO6JFdkKK4f_InxVs8Iv2T4_PDU6csC-GEmFdi5iTNULqaafBUZNNnAecRHIUXaj_hoR-5cYB56-Hbah1oydtwlAH8YgHoH495j8lGNs7ip4TyVgIOsh_7UZgI6QZtL4IRaOTHTEdM8KBGxJwjVFgmTcfaHSO1YnccE8owkpI18q4im9isIdcRtObspuYhsaDEFdi16wj9VYRxXqqiXDGVc-VaaiQG04ikQCkrytLbsl7Uv_xpfUkiqmeE4XcTBviAsDtnaLXoSMXNNfKyugzaDJeodBaPC8ABdxwcdC6ba3DAR8aRs-vWyBMrdYsONDHfkGjDa1mSxwoBs6kvX8nSryaruuDovvo1smcld4nkKO0fqPF0qKJCcQbKrEZerUMrAI23XQ4deb0Cb1hMFDQNC5XHirteW16BWDZ9SxERM6R5gOgtNIrKsOJYbnDLaV91WUxVNsIDkOYK2Brs9LP1X-Q52QKJE3ZucZdszKZF_ILcCn_M0nxaB6161q8b3WqgBCgPWZ1sfjzu9s7grONaeI6Qdwz8bGAPod_7DWXR3Bo |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3rb9MwELfGQDA08RivwhhG2hBIDYsfbRwkhKaVqdW2ahJTtW-W8yoVXVKahmp_FOJf5BwnKRVdx5d94FMq9y51k7vf3dm-O4S2WQPsWhgxi0WRsrgviAVywy3aVKBfioKM8LzZhNPtirMz92QF_SpzYfSxyhITc6AOEl-vke-SJkge2E6bfhp9t3TXKL27WrbQMGJxGF5MIWRLP3Za8H53KD34fLrftoquApavyxJMrKjhC1sRBYZONBziURrAlTNfORH1ncCGYJNQx2FNpTwlqAtX4cEn4oH4MsLgxjfQTc4o02ok9smiRMz8TP0sZWj3SzX4lvB3TVtwbonLjOH6SKXwiiLTW2OR8_v3Gc6i0uldtDYFJIrz1Kw_TOXB_f_uIT9A9wqvHO8ZNXqIVsJ4A90-Ls4dbKB1s7qJTdLWI_TTtEqoY93XQscydaziAJcrq1hvYOTNWvPh8zzEgXAHQ4SA251eHU8yLxz72TBJB6nhPVdDBWCATd4oJmC_AVsI-4AVnpXbBlJTRCa_FTjv2MwEm3QUnES4ZbbcsD4heoH1LR6j3vU8vSdoNU7i8BnCtBlBCOCETuBHXNieywKIsQMnJCognHo1xEsRlH5RFl53JxnKBef_CJe55EpRQ-8rtpGpi3IVQ7OUb1km_YKZkmC5r2J0FjGGaQG2qSQypdI23JoZjL9mBU5RcRb-pPET_-VHt-ZUsPqPFOJ7m9hAsFlqkJxNpFKfGnpdfQ14rTfhVBwmGdBAwAEhCBWNJTQQBei1AduuoadGzWcTaOiKStyFxzIHABWBrhc__008-JrXjedUO-hODW0bqJhjaQ16ezIZ92WQSUoArmtoZxlZBmTUtSlM5M0Cun42kjDUz2QaSmozV1xCWAx9G2hCXQOOASGbQZiMdU-1NKctFrblNBvLeKgvwJpKEGvwRJ4vfyOv0J326fGRPOp0D1-gNdA-blZSN9HqZJyFL9Et_8dkkI63ckjHSF07vv0Gk3IuTA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9NAEB6VFFVFFUe5AqUsUotAqon3SLxBQqiQVq0KUQSo6ttqfZWI1AlxTNUfxS_gzzHrtR0i0paXPvDkaDPjbOzZb2Z25wDY4E3Ua1HMHR7H2hGBpA7KjXBYS-P60gxlROTNJrxuVx4dtXsL8KvMhTFhlSUm5kAdDgOzR96gLZQ81J0ua8RFWESvs_t29N0xHaTMSWvZTsOKyEF0doruW_pmv4PvepOx3Z0v7_ecosOAE5gSBRMnbgbS1VSj0pNNj_qMhXgVPNBezAIvdNHxpMzzeEtrX0vWxqv08RP1UZQ55Xjja7DocfR6arD4bqfb-zQvLTOPsJ8mEDU-V4MvqHjZcqUQjjxPNa6MdIovLLadNuaZwn9HdBZ1T2_A8iniUpInav2hOHdv_deP_DbcLOx1sm0X2B1YiJJVWPpYRCSsword9yQ2nesu_LRNFLaI6XhhvJwtopOQlHuuxBxt5G1c8-GT3PlBR4ig70D29g-3yCTzo3GQDYZpP7W8J3qgESaIzSglFDU7og7lr4km00LcSGrLy-S3QrOe2JkQm6hChjHp2MM4YmJHz4i5xT04vJqndx9qyTCJHgJhrRidAy_ywiAW0vXbPETvO_QiqkMqmF8HUYqjCoqC8aZvyUDNiQykQuVSrGQdXlVsI1sx5TKGVinrqkwHRgWmUKdfxujNY4zSAoZTRVXKlGu5DTOaBYYVOWXFWVia1oL8lx9dn1mO1X9k6Pm71EWCtXI1qelEqqVUh2fV14jk5nhOJ9EwQxp0RdA5YbJ5AQ36B2bXwHXr8MAu-ekEmqbWkmjjY5kBg4rAVJKf_Sbpf80rygtmTHevDhsWNmZYOv3DbTUcH6swU4wikNdh8yKyDMlY22U4kedz6I6zkcKh40ylkWIub8tzCIuhb31DaKrDcSTkUzhTiem2lua0xZa3Os3GKhmYC7KmCsUabZRHF7-Rp7CEsKY-7HcPHsMyLj5ht1jXoDYZZ9ETuB78mPTT8XqB7wT0lQPcb5_jOKo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global%2C+regional%2C+and+national+incidence+and+mortality+for+HIV%2C+tuberculosis%2C+and+malaria+during+1990-2013%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2013&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Lim%2C+Stephen+S&rft.au=Roberts%2C+D+Allen&rft.au=Brown%2C+Jonathan+C&rft.au=Dicker%2C+Daniel&rft.date=2014&rft.pub=Elsevier+Limited&rft.issn=0140-6736&rft.eissn=1474-547X&rft.volume=384&rft.issue=9947&rft.spage=1005&rft_id=info:doi/10.1016%2FS0140-6736%2814%2960844-8&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3492119011 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01406736%2FS0140673614X61027%2Fcov150h.gif |